CA2714551A1 - Deactivating an explosive composition using enzymes - Google Patents
Deactivating an explosive composition using enzymes Download PDFInfo
- Publication number
- CA2714551A1 CA2714551A1 CA2714551A CA2714551A CA2714551A1 CA 2714551 A1 CA2714551 A1 CA 2714551A1 CA 2714551 A CA2714551 A CA 2714551A CA 2714551 A CA2714551 A CA 2714551A CA 2714551 A1 CA2714551 A1 CA 2714551A1
- Authority
- CA
- Canada
- Prior art keywords
- deactivating agent
- cartridge
- explosive
- explosive composition
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002360 explosive Substances 0.000 title claims abstract description 288
- 239000000203 mixture Substances 0.000 title claims abstract description 214
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 77
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 77
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 192
- 238000000034 method Methods 0.000 claims abstract description 28
- 238000005474 detonation Methods 0.000 claims abstract description 13
- 238000002955 isolation Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 79
- 230000000694 effects Effects 0.000 claims description 45
- 239000003153 chemical reaction reagent Substances 0.000 claims description 22
- 239000012528 membrane Substances 0.000 claims description 16
- 238000000586 desensitisation Methods 0.000 claims description 13
- 230000007613 environmental effect Effects 0.000 claims description 12
- 239000003599 detergent Substances 0.000 claims description 10
- 230000037361 pathway Effects 0.000 claims description 6
- 229940088598 enzyme Drugs 0.000 description 71
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 description 44
- 239000000026 Pentaerythritol tetranitrate Substances 0.000 description 44
- 229960004321 pentaerithrityl tetranitrate Drugs 0.000 description 44
- 230000015556 catabolic process Effects 0.000 description 37
- 238000006731 degradation reaction Methods 0.000 description 36
- 244000005700 microbiome Species 0.000 description 34
- HZTVIZREFBBQMG-UHFFFAOYSA-N 2-methyl-1,3,5-trinitrobenzene;[3-nitrooxy-2,2-bis(nitrooxymethyl)propyl] nitrate Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O.[O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O HZTVIZREFBBQMG-UHFFFAOYSA-N 0.000 description 28
- 239000000463 material Substances 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 26
- SPSSULHKWOKEEL-UHFFFAOYSA-N 2,4,6-trinitrotoluene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O SPSSULHKWOKEEL-UHFFFAOYSA-N 0.000 description 24
- 239000000015 trinitrotoluene Substances 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 21
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 18
- 239000012141 concentrate Substances 0.000 description 18
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 16
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 108010093894 Xanthine oxidase Proteins 0.000 description 15
- 230000004888 barrier function Effects 0.000 description 15
- 229940039748 oxalate Drugs 0.000 description 15
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- 102100033220 Xanthine oxidase Human genes 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 14
- 102000004316 Oxidoreductases Human genes 0.000 description 13
- 108090000854 Oxidoreductases Proteins 0.000 description 13
- 239000002585 base Substances 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 13
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 description 12
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 12
- 230000009471 action Effects 0.000 description 12
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 12
- -1 Sodium carbonate Pentasodium triphosphate Sodium Chemical compound 0.000 description 11
- 229910002651 NO3 Inorganic materials 0.000 description 10
- 239000013615 primer Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 230000000593 degrading effect Effects 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 239000006227 byproduct Substances 0.000 description 8
- 230000009849 deactivation Effects 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 6
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 6
- 239000004115 Sodium Silicate Substances 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 231100000647 material safety data sheet Toxicity 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 238000009877 rendering Methods 0.000 description 6
- 229910052911 sodium silicate Inorganic materials 0.000 description 6
- 229940075420 xanthine Drugs 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 230000000977 initiatory effect Effects 0.000 description 5
- 238000001746 injection moulding Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 239000008057 potassium phosphate buffer Substances 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 5
- 235000019832 sodium triphosphate Nutrition 0.000 description 5
- 108020004465 16S ribosomal RNA Proteins 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000003359 percent control normalization Methods 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 108010065511 Amylases Proteins 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 3
- 101710088194 Dehydrogenase Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 3
- 108010077190 glyceryl trinitrate reductase Proteins 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 150000002823 nitrates Chemical class 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 3
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 3
- 229940039790 sodium oxalate Drugs 0.000 description 3
- 229940045872 sodium percarbonate Drugs 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
- PHOLIFLKGONSGY-CSKARUKUSA-N (e)-(3-methyl-1,3-benzothiazol-2-ylidene)hydrazine Chemical compound C1=CC=C2S\C(=N\N)N(C)C2=C1 PHOLIFLKGONSGY-CSKARUKUSA-N 0.000 description 2
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- 241000217808 Pseudomonas sp. ADP Species 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 239000001166 ammonium sulphate Substances 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000006065 biodegradation reaction Methods 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 159000000011 group IA salts Chemical class 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000005065 mining Methods 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- UZGLIIJVICEWHF-UHFFFAOYSA-N octogen Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)CN([N+]([O-])=O)C1 UZGLIIJVICEWHF-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000012289 standard assay Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 108020005065 3' Flanking Region Proteins 0.000 description 1
- VDZIEFZQEFFUKW-UHFFFAOYSA-N 3,7-dihydropurine-2,6-dione;7,9-dihydro-3h-purine-2,6,8-trione;3,7-dihydropurin-6-one Chemical compound O=C1NC=NC2=C1NC=N2.O=C1NC(=O)NC2=C1NC=N2.N1C(=O)NC(=O)C2=C1NC(=O)N2 VDZIEFZQEFFUKW-UHFFFAOYSA-N 0.000 description 1
- NEGFNJRAUMCZMY-UHFFFAOYSA-N 3-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=CC(C(O)=O)=C1 NEGFNJRAUMCZMY-UHFFFAOYSA-N 0.000 description 1
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-n-(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- RGHNJXZEOKUKBD-MGCNEYSASA-N D-galactonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-MGCNEYSASA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 108010076804 DNA Restriction Enzymes Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000588772 Morganella morganii Species 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- 101800000135 N-terminal protein Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010063734 Oxalate oxidase Proteins 0.000 description 1
- 101800001452 P1 proteinase Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 101000933790 Sarocladium sp Cyanuric acid amidohydrolase Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 102000005773 Xanthine dehydrogenase Human genes 0.000 description 1
- 108010091383 Xanthine dehydrogenase Proteins 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000003975 dentin desensitizing agent Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- JYIMWRSJCRRYNK-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4] JYIMWRSJCRRYNK-UHFFFAOYSA-N 0.000 description 1
- ULAUBQTVYAVTFT-UHFFFAOYSA-N dinitro carbonate Chemical compound [O-][N+](=O)OC(=O)O[N+]([O-])=O ULAUBQTVYAVTFT-UHFFFAOYSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- ISWNSRXHJZNMRB-UHFFFAOYSA-L disodium dodecyl benzenesulfonate carbonate Chemical compound C([O-])([O-])=O.C1(=CC=CC=C1)S(=O)(=O)OCCCCCCCCCCCC.[Na+].[Na+] ISWNSRXHJZNMRB-UHFFFAOYSA-L 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 229940013640 flavin mononucleotide Drugs 0.000 description 1
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 1
- 239000011768 flavin mononucleotide Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- PMYUVOOOQDGQNW-UHFFFAOYSA-N hexasodium;trioxido(trioxidosilyloxy)silane Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-] PMYUVOOOQDGQNW-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229940076266 morganella morganii Drugs 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 101150054342 ner gene Proteins 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 108010040510 pentaerythritol tetranitrate reductase Proteins 0.000 description 1
- ISKBHNVAUOIYIA-UHFFFAOYSA-I pentasodium phosphonato phosphate hydroxide Chemical compound [OH-].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O ISKBHNVAUOIYIA-UHFFFAOYSA-I 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000006894 reductive elimination reaction Methods 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 1
- OFGIQHQRUSYPOU-UHFFFAOYSA-N sodium;tridecylbenzene Chemical compound [Na].CCCCCCCCCCCCCC1=CC=CC=C1 OFGIQHQRUSYPOU-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- MSLRPWGRFCKNIZ-UHFFFAOYSA-J tetrasodium;hydrogen peroxide;dicarbonate Chemical compound [Na+].[Na+].[Na+].[Na+].OO.OO.OO.[O-]C([O-])=O.[O-]C([O-])=O MSLRPWGRFCKNIZ-UHFFFAOYSA-J 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C06—EXPLOSIVES; MATCHES
- C06B—EXPLOSIVES OR THERMIC COMPOSITIONS; MANUFACTURE THEREOF; USE OF SINGLE SUBSTANCES AS EXPLOSIVES
- C06B21/00—Apparatus or methods for working-up explosives, e.g. forming, cutting, drying
- C06B21/0091—Elimination of undesirable or temporary components of an intermediate or finished product, e.g. making porous or low density products, purifying, stabilising, drying; Deactivating; Reclaiming
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/02—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by biological methods, i.e. processes using enzymes or microorganisms
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
- C02F3/342—Biological treatment of water, waste water, or sewage characterised by the microorganisms used characterised by the enzymes used
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8259—Phytoremediation
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F42—AMMUNITION; BLASTING
- F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
- F42B3/00—Blasting cartridges, i.e. case and explosive
- F42B3/10—Initiators therefor
- F42B3/192—Initiators therefor designed for neutralisation on contact with water
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F42—AMMUNITION; BLASTING
- F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
- F42B33/00—Manufacture of ammunition; Dismantling of ammunition; Apparatus therefor
- F42B33/06—Dismantling fuzes, cartridges, projectiles, missiles, rockets or bombs
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F42—AMMUNITION; BLASTING
- F42D—BLASTING
- F42D5/00—Safety arrangements
- F42D5/04—Rendering explosive charges harmless, e.g. destroying ammunition; Rendering detonation of explosive charges harmless
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/06—Explosives, propellants or pyrotechnics, e.g. rocket fuel or napalm
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Business, Economics & Management (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Emergency Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental & Geological Engineering (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Water Supply & Treatment (AREA)
- Hydrology & Water Resources (AREA)
- Biodiversity & Conservation Biology (AREA)
- Catching Or Destruction (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
- Fire-Extinguishing Compositions (AREA)
- Disintegrating Or Milling (AREA)
Abstract
A method of deactivating an explosive composition provided in an explosive cartridge, which method comprises exposing the explosive composition to a deactivating agent that renders the explosive composition insensitive to detonation, wherein the deactivating agent is an enzyme used in isolation from any living cell with which it might normally be associated or produced.
Description
DEACTIVATING AN EXPLOSIVE COMPOSITION USING ENZYMES
The present invention relates to a method of deactivating an explosive composition in order to render the composition safe. The present invention also relates to a cartridge that contains an explosive composition and that is adapted to achieve deactivation of the explosive composition in the event that it is not detonated as intended during use.
Explosives are used in a significant number of commercial applications, such as mining, quarrying and seismic exploration. In mining and quarrying a detonator is typically used to initiate a cartridged primer charge that in turn detonates bulk explosive.
In seismic exploration a relatively small cartridged explosive charge is initiated using a detonator and the shock waves that are generated are monitored and analysed.
When a charge fails to detonate as intended there are obvious safety and security issues. In that event, it may be possible to recover the charge, although this is not always possible for a variety of reasons. For example, in seismic exploration where charges or trains of charges are positioned and detonated, recovery of undetonated charges can be difficult, especially when the charge(s) is/are positioned in an underground borehole and the borehole has been backfilled, as is common practice. There are therefore instances where undetonated charges remain unrecovered in the field. In such cases, and as a general point, it would therefore be desirable to render safe any undetonated and unrecovered explosive charges. A variety of approaches to address this need already exist.
By way of example, US 3,948,177, describes an explosive cartridge for underwater blasting which is said to be self-disarming in the event of an underwater misfire. The cartridge comprises a closed shell including an internal conduit. Water external to the cartridge is prevented from flowing into the conduit by a watertight seal. The force of a percussion impact initiation can however break the watertight seal thereby allowing water to flow into the conduit and contact with explosive composition contained. In turn, water can dissolve the (nitrocarbonate) explosive possibly also causing it to flow out of the body of the cartridge. The result is desensitisation. Whilst generally useful, a problem with this Substitute Sheet (Rule 26) RO/AU
bPuCC~SP~~IFICA71oNSOn;e\2075,ZS,a,mcd,ag a1Aõ,.do01õõR Received 3 August 2009 approach is that desensitisation is contingent upon some form of specific force associated with a misfire to break the watertight seal. If there is no applied force resulting from a misfire, the cartridge would not be disarmed by the action of water.
Other approaches, such as those described in WO 97/19253 and WO 98/55822, rely on the use of micro-organisms to effect bio-remediation of an explosive composition in the event that the composition is not detonated as intended. However, being biological in nature, care needs to be taken to provide the micro-organisms in a form .that is active or potential to be active, and care needs to be taken not to destroy the micro-organism thereby rendering them useless. It will also be necessary to supply micro-organisms with suitable nutrients/metabolites in order to sustain them when they are required to be active. Approaches using micro-organisms may also lead to unwanted introduction or leakage of possibly exotic micro-organisms and/or chemicals into the environment. Thus, the use of micro-organisms in this context is not without practical problems.
The present invention seeks to provide an alternative approach to rendering safe explosive compositions that does not suffer the disadvantages described above. .
Accordingly, in one embodiment, the present invention provides a method of deactivating an explosive -composition provided in an explosive cartridge, which method comprises AS
contacting the explosive composition with a' deactivating agent in a form that renders the explosive composition insensitive to detonation after a predetermined period of time, wherein the deactivating agent is provided in the explosive cartridge and wherein the deactivating agent is an enzyme used in isolation from any living cell with which, it might normally be associated or"produced.. In the present invention, and as will be explained in more detail below, the deactivating agent is an enzyme. The enzyme is used in isolation from any living cell with which it might normally be associated or produced. Unless otherwise stated the term deactivating agent is used to denote such. enzymes. Mixtures of enzymes may be used.
This definition is intended to embrace naturally occurring or produced enzymes that have been isolated or extracted and synthetic enzymes.
In accordance with the present invention, the action of a deactivating agent on the Amended Sheet IPEA/AU
The present invention relates to a method of deactivating an explosive composition in order to render the composition safe. The present invention also relates to a cartridge that contains an explosive composition and that is adapted to achieve deactivation of the explosive composition in the event that it is not detonated as intended during use.
Explosives are used in a significant number of commercial applications, such as mining, quarrying and seismic exploration. In mining and quarrying a detonator is typically used to initiate a cartridged primer charge that in turn detonates bulk explosive.
In seismic exploration a relatively small cartridged explosive charge is initiated using a detonator and the shock waves that are generated are monitored and analysed.
When a charge fails to detonate as intended there are obvious safety and security issues. In that event, it may be possible to recover the charge, although this is not always possible for a variety of reasons. For example, in seismic exploration where charges or trains of charges are positioned and detonated, recovery of undetonated charges can be difficult, especially when the charge(s) is/are positioned in an underground borehole and the borehole has been backfilled, as is common practice. There are therefore instances where undetonated charges remain unrecovered in the field. In such cases, and as a general point, it would therefore be desirable to render safe any undetonated and unrecovered explosive charges. A variety of approaches to address this need already exist.
By way of example, US 3,948,177, describes an explosive cartridge for underwater blasting which is said to be self-disarming in the event of an underwater misfire. The cartridge comprises a closed shell including an internal conduit. Water external to the cartridge is prevented from flowing into the conduit by a watertight seal. The force of a percussion impact initiation can however break the watertight seal thereby allowing water to flow into the conduit and contact with explosive composition contained. In turn, water can dissolve the (nitrocarbonate) explosive possibly also causing it to flow out of the body of the cartridge. The result is desensitisation. Whilst generally useful, a problem with this Substitute Sheet (Rule 26) RO/AU
bPuCC~SP~~IFICA71oNSOn;e\2075,ZS,a,mcd,ag a1Aõ,.do01õõR Received 3 August 2009 approach is that desensitisation is contingent upon some form of specific force associated with a misfire to break the watertight seal. If there is no applied force resulting from a misfire, the cartridge would not be disarmed by the action of water.
Other approaches, such as those described in WO 97/19253 and WO 98/55822, rely on the use of micro-organisms to effect bio-remediation of an explosive composition in the event that the composition is not detonated as intended. However, being biological in nature, care needs to be taken to provide the micro-organisms in a form .that is active or potential to be active, and care needs to be taken not to destroy the micro-organism thereby rendering them useless. It will also be necessary to supply micro-organisms with suitable nutrients/metabolites in order to sustain them when they are required to be active. Approaches using micro-organisms may also lead to unwanted introduction or leakage of possibly exotic micro-organisms and/or chemicals into the environment. Thus, the use of micro-organisms in this context is not without practical problems.
The present invention seeks to provide an alternative approach to rendering safe explosive compositions that does not suffer the disadvantages described above. .
Accordingly, in one embodiment, the present invention provides a method of deactivating an explosive -composition provided in an explosive cartridge, which method comprises AS
contacting the explosive composition with a' deactivating agent in a form that renders the explosive composition insensitive to detonation after a predetermined period of time, wherein the deactivating agent is provided in the explosive cartridge and wherein the deactivating agent is an enzyme used in isolation from any living cell with which, it might normally be associated or"produced.. In the present invention, and as will be explained in more detail below, the deactivating agent is an enzyme. The enzyme is used in isolation from any living cell with which it might normally be associated or produced. Unless otherwise stated the term deactivating agent is used to denote such. enzymes. Mixtures of enzymes may be used.
This definition is intended to embrace naturally occurring or produced enzymes that have been isolated or extracted and synthetic enzymes.
In accordance with the present invention, the action of a deactivating agent on the Amended Sheet IPEA/AU
explosive composition is responsible for rendering the explosive composition insensitive to detonation, i.e. safe. Herein, unless otherwise evident, when it is indicated that an explosive composition is rendered insensitive to detonation means that the explosive composition has, by action of the deactivating agent, been desensitised at least to the extent that the normal (predetermined) method of initiation of the explosive composition is no longer effective. Thus, for an explosive composition that is known to be detonated using a particular type of initiating device, in accordance with the present invention the explosive charge is rendered insensitive to detonation if it is no longer possible for it to be initiated in that way. The fact that an explosive composition has been rendered insensitive to detonation does not mean that the explosive charge is completely undetonable (although this is of course a possibility). At the very least, the extent of desensitisation effected by the deactivating agent in accordance with the invention results in the explosive composition being insensitive to the initiation means that was otherwise and originally intended to cause detonation of the explosive composition.
In an embodiment of the present invention, as well as deactivating the explosive composition, the enzyme converts the explosive composition (or components thereof) into one or more compounds that are more environmentally acceptable.
When the enzyme is derived from a living cell it may be derived from a microorganism, animal or plant cell. Microorganisms capable of degrading explosive material are known in the art and to the extent that this activity is attributed to enzymes associated with or produced by the microorganism, the microorganism may be a useful source of enzymes for the present invention. Examples of microorganisms that are known to exhibit that ability include Pseudomonas spp., Escherichia coli, Morganella morganii, Rhodococcus spp., Comamanos spp., and denitrifying bacteria. Suitable Pseudomonas spp.
microorganisms include microorganisms in the group aeruginosa, fluorescens, acidovorans, mendocina, cepacia.
The enzymes used in accordance with this embodiment must be functional under the conditions of intended use.
In an embodiment of the present invention, as well as deactivating the explosive composition, the enzyme converts the explosive composition (or components thereof) into one or more compounds that are more environmentally acceptable.
When the enzyme is derived from a living cell it may be derived from a microorganism, animal or plant cell. Microorganisms capable of degrading explosive material are known in the art and to the extent that this activity is attributed to enzymes associated with or produced by the microorganism, the microorganism may be a useful source of enzymes for the present invention. Examples of microorganisms that are known to exhibit that ability include Pseudomonas spp., Escherichia coli, Morganella morganii, Rhodococcus spp., Comamanos spp., and denitrifying bacteria. Suitable Pseudomonas spp.
microorganisms include microorganisms in the group aeruginosa, fluorescens, acidovorans, mendocina, cepacia.
The enzymes used in accordance with this embodiment must be functional under the conditions of intended use.
In the invention the enzyme(s) are used in isolation from the cells that otherwise produce or are associated with the enzyme(s). In this case the enzyme is provided in a substantially purified form or in a cell-free form. The latter may be a cell free extract or the enzyme may be provided as a component of a cell-free composition. The enzyme may be produced and isolated by conventional techniques. Enzymes that are known to be useful in degrading explosive materials are known in the art. As an alternative the enzymes may be synthetic and thus not derived from living cells It is also known that certain plants have a phytoremediating/rhizoremediating effect on explosive materials. To the extent that this effect is due to enzymes that are produced by or associated with the living cells of the plant, the plant may be a useful source of enzymes for the present invention.
Laundry and dishwasher detergents may include suitable enzymes for use in the present invention and the detergent may represent a convenient format in which the enzyme is provided into the explosive cartridge. In this embodiment (and generally) it may be appropriate to provide the enzyme with co-factors and the like that are required for the relevant functionality or for potentiating the relevant functionality.
Temperature and pH
conditions may also need to be taken into account.
In an embodiment of the present invention it may be desirable to employ two different deactivating agents (i.e. with different activities) to effect desensitisation of the explosive composition. In this case one of the desensitising agents acts to degrade the explosive composition to some by-product, with the other deactivating agent acting on the by-product. The latter deactivating agent has the effect of thermodynamically increasing the efficiency of the first deactivating agent due to degradation of the by-product associated with the deactivating activity of the first deactivating agent on the explosive composition.
This embodiment may be implemented with more than two deactivating agents, as appropriate. In this embodiment at least one deactivating agent should be as required in accordance with the present invention. The other deactivating agent(s) may be of the same or different type.
Laundry and dishwasher detergents may include suitable enzymes for use in the present invention and the detergent may represent a convenient format in which the enzyme is provided into the explosive cartridge. In this embodiment (and generally) it may be appropriate to provide the enzyme with co-factors and the like that are required for the relevant functionality or for potentiating the relevant functionality.
Temperature and pH
conditions may also need to be taken into account.
In an embodiment of the present invention it may be desirable to employ two different deactivating agents (i.e. with different activities) to effect desensitisation of the explosive composition. In this case one of the desensitising agents acts to degrade the explosive composition to some by-product, with the other deactivating agent acting on the by-product. The latter deactivating agent has the effect of thermodynamically increasing the efficiency of the first deactivating agent due to degradation of the by-product associated with the deactivating activity of the first deactivating agent on the explosive composition.
This embodiment may be implemented with more than two deactivating agents, as appropriate. In this embodiment at least one deactivating agent should be as required in accordance with the present invention. The other deactivating agent(s) may be of the same or different type.
Typically, the deactivating agent will itself cause suitable desensitisation of the explosive composition. However, it is also possible that further desensitisation may be achieved through the combined activity of the deactivating agent and another reagent useful in deactivating the explosive composition. The another reagent may be a microorganism, (non-biological) chemical, and/or a plant or plant extract/derivative. In the following, unless context requires otherwise, reference to an enzyme/deactivating agent may be taken as reference to the combined use of the enzyme/deactivating agent and the another reagent.
In this case the relative order of activity of the deactivating agent and the another reagent is not especially critical. For example, the another reagent may degrade the explosive composition into a particular by-product that is then acted upon (degraded) by the deactivating agent, or vice versa. In this case the combined activity of the agent and reagent give a beneficial effect in terms of reaction thermodynamics.
Of course, the deactivating agent and another reagent may have the same general activity with respect to the explosive composition. In this case other reagents may be employed to enhance the thermodynamics of the relevant reaction(s) by consuming reaction(s) by-products.
In one embodiment the another reagent may be a reagent external to the explosive cartridge that will find its way or be introduced into the cartridge during use thereof and that can contribute to desensitisation of the explosive composition. Such reagents may be naturally present in the environment in which the explosive cartridge is to be used. In this embodiment the explosive cartridge will be adapted to allow the relevant reagent to be introduced into or enter the explosive cartridge as required. By way of example, the explosive cartridge may be designed to allow environmental water to enter the body of the cartridge and contact the explosive composition, assuming of course that water has a desensitising effect on the emulsion.
By way of further example, the cartridge may be adapted to allow ingress of naturally-occurring microorganisms (or other remediating agent(s)), for example water-borne microorganisms, that exist naturally in the environment in which the explosive cartridge is being used and that are capable of remediating the explosive composition contained in the cartridge. The cartridge may be provided with a nutrient source to promote uptake and proliferation of such microorganisms (or agent(s)). In this case water serves as a vehicle that transports the microorganisms into contact with the explosive composition.
Central to the present invention is the nature of the deactivating agent and its use in the context of desensitising an explosive composition provided in an explosive cartridge. In certain embodiments of the invention the explosive cartridge may be of known design. For example, the explosive cartridge may comprise a reservoir (or chamber) in which the deactivating agent is provided and a separate component, typically in the form of a shell (or cartridge,) in which the explosive composition is provided. The reservoir and shell are adapted. to be connected to each other. The act of connecting the reservoir to the shell may cause release of the deactivating agent from the reservoir so that the deactivating agent comes into contact with the explosive composition. In another embodiment valve means may be provided between the reservoir and shell, as part of one or both components, to regulate when release of deactivating agent takes place. This type of arrangement is disclosed, for example, in US 5,736,669 and US 5,763,815, the contents of which are incorporated by reference.
In another embodiment the deactivating agent and explosive composition may be provided adjacent to each other but contact of them is prevented by use of a physical barrier element. Prior to use of the explosive cartridge, that is positioning and priming of the explosive cartridge, the barrier element prevents contact between the deactivation agent and explosive composition. In embodiments of the present invention the barrier element is breached or removed instantaneously when the explosive cartridge is being used in the field. In other embodiments the barrier element remains in place between the deactivating agent and explosive composition when the explosive cartridge is actually positioned and primed but some mechanism for delayed removal of the barrier element is activated. The barrier element may be breached/removed by chemical, mechanical or electrical means.
In this case the relative order of activity of the deactivating agent and the another reagent is not especially critical. For example, the another reagent may degrade the explosive composition into a particular by-product that is then acted upon (degraded) by the deactivating agent, or vice versa. In this case the combined activity of the agent and reagent give a beneficial effect in terms of reaction thermodynamics.
Of course, the deactivating agent and another reagent may have the same general activity with respect to the explosive composition. In this case other reagents may be employed to enhance the thermodynamics of the relevant reaction(s) by consuming reaction(s) by-products.
In one embodiment the another reagent may be a reagent external to the explosive cartridge that will find its way or be introduced into the cartridge during use thereof and that can contribute to desensitisation of the explosive composition. Such reagents may be naturally present in the environment in which the explosive cartridge is to be used. In this embodiment the explosive cartridge will be adapted to allow the relevant reagent to be introduced into or enter the explosive cartridge as required. By way of example, the explosive cartridge may be designed to allow environmental water to enter the body of the cartridge and contact the explosive composition, assuming of course that water has a desensitising effect on the emulsion.
By way of further example, the cartridge may be adapted to allow ingress of naturally-occurring microorganisms (or other remediating agent(s)), for example water-borne microorganisms, that exist naturally in the environment in which the explosive cartridge is being used and that are capable of remediating the explosive composition contained in the cartridge. The cartridge may be provided with a nutrient source to promote uptake and proliferation of such microorganisms (or agent(s)). In this case water serves as a vehicle that transports the microorganisms into contact with the explosive composition.
Central to the present invention is the nature of the deactivating agent and its use in the context of desensitising an explosive composition provided in an explosive cartridge. In certain embodiments of the invention the explosive cartridge may be of known design. For example, the explosive cartridge may comprise a reservoir (or chamber) in which the deactivating agent is provided and a separate component, typically in the form of a shell (or cartridge,) in which the explosive composition is provided. The reservoir and shell are adapted. to be connected to each other. The act of connecting the reservoir to the shell may cause release of the deactivating agent from the reservoir so that the deactivating agent comes into contact with the explosive composition. In another embodiment valve means may be provided between the reservoir and shell, as part of one or both components, to regulate when release of deactivating agent takes place. This type of arrangement is disclosed, for example, in US 5,736,669 and US 5,763,815, the contents of which are incorporated by reference.
In another embodiment the deactivating agent and explosive composition may be provided adjacent to each other but contact of them is prevented by use of a physical barrier element. Prior to use of the explosive cartridge, that is positioning and priming of the explosive cartridge, the barrier element prevents contact between the deactivation agent and explosive composition. In embodiments of the present invention the barrier element is breached or removed instantaneously when the explosive cartridge is being used in the field. In other embodiments the barrier element remains in place between the deactivating agent and explosive composition when the explosive cartridge is actually positioned and primed but some mechanism for delayed removal of the barrier element is activated. The barrier element may be breached/removed by chemical, mechanical or electrical means.
Mechanisms useful in implementation of this embodiment of the invention are known in the art, for example from US 6,120,627, US 6,660,112, US 6,644,200 and US
7,077,044, the contents of which are incorporated by reference.
Typically, the external configuration of the explosive cartridge is cylindrical with the deactivating agent and explosive composition occupying respective chambers within the body of the cartridge. In this embodiment the explosive cartridge is invariably sealed so that there is no risk of escape of components, for example, during storage and/or transportation. Sealing may be achieved by conventional techniques depending upon the materials used to form the cartridge. If the cartridge is formed from plastic, the body of the cartridge, including the respective chambers of it, may be formed by injection moulding with the chambers of the cartridge being loaded with the deactivating agent and explosive composition as required, with subsequent sealing (heat sealing, for example) in order to seal the inlets through which these components are supplied into respective chambers in the body of the cartridge.
The cartridge may be made up of independent components that are adapted to be attached to each other as the cartridge is being loaded with respective components and when used in the field. By way of example, the explosive composition may be provided in a chamber that is adapted to be secured to another component comprising a chamber for the deactivating agent. The chamber for the deactivating agent may be of single piece construction, for example formed by injection moulding of a suitable plastics material, and include at least one detonator receiving channel as part of the construction.
The chamber for the deactivating agent may be provided as part of a cap well or lid piece for the chamber housing the explosive composition. The individual components may be attached to each other by any suitable mechanism, such as interference (friction) fit, male-female screw threading or clip fitting. In this case the explosive composition may be loaded into the respective chamber and the lid secured to the top of the explosive composition chamber. If the explosive composition is a fluid, the attachment must be such that loss of explosive composition is prevented. However, if the explosive composition is solid in nature, for example when the explosive composition is cast hot and allowed to solidify, the attachment may be loose fitting, and this may be beneficial in terms of allowing water to enter the cartridge, as will be explained. The cap well (lid piece) will also generally include a lid/seal over its open end, and this may also allow water to enter the cartridge.
As a further alternative, rather than relying on separate chambers that are integrally formed as parts of the cartridge structure, the deactivating agent and/or explosive composition may be provided in independent containers that are inserted into a rigid cartridge body. In this case it will be appreciated that the cartridge is made up of at least two independent parts and that in use the cartridge is assembled from those parts.
The material(s) used to form the cartridge of the invention should not be corroded by or be reactive towards the deactivating agent and explosive composition to be contained. Thus, the cartridge will retain its structural integrity.
In one embodiment the barrier element takes the form of an internal wall or internal wall portion (membrane) separating the chambers containing the deactivating agent and explosive composition. When this wall or wall portion is breached or removed the deactivating agent and explosive composition come into direct contact with each other. In accordance with the invention, this occurs only during use. Thus, in one embodiment the wall or wall portion may be ruptured by insertion of a detonator into the explosive cartridge (detonators are invariably used to initiate detonation), or by the act of connecting one cartridge to another to form a train of cartridges, as is common practice.
With respect to use of a detonator, the cartridge is usually adapted to receive the detonator in a suitably shaped passage extended axially within the body of the cartridge. The cartridge may be adapted to receive a single detonator or more than one detonator in respective, suitably shaped passages. In this regard it should be understood that explosive cartridges for use in seismic exploration, for example, generally allow inclusion of two detonators, a primary detonator and a secondary (back-up) detonator in case the primary detonator does not detonate as intended.
In the embodiment described above the barrier element may extend across this detonator-receiving passage such that, when the detonator is pushed into position in the cartridge, the wall originally separating the deactivating agent and explosive composition is ruptured thereby allowing these components to come into direct contact with each other.
Alternatively, the action of inserting the detonator into the cartridge may cause a separate component to rupture the wall. This component may be a needle-like structure, rigid tube, or similar.
To achieve release of the deactivating agent when cartridges are coupled together in a train, the lower end of the cartridge may include a suitably shaped extension for insertion into the detonator-receiving passage of an adjacent cartridge (of the same design).
Insertion of this extension into the detonator-receiving passage has the same effect as inserting a detonator in that the wall/membrane separating the deactivating agent and explosive composition is ruptured. Alternatively, the upper end of the cartridge may include a component that is adapted to be displaced downwardly (or upwardly) when the cartridges are coupled together and that causes the wall membrane to be ruptured. To facilitate attachment explosive cartridges in accordance with the present invention may also include suitable engagement or retaining means. For example, the lower end of the cartridge may include external threads with the upper end including corresponding internal threads thereby allowing adjacent cartridges to be secured to each other. It will be appreciated that the external shape of the lower end of the cartridge is adapted to mate with the upper end of an adjacent cartridge. In the particular embodiment described, the act of engaging and screwing cartridges together may cause rupture of the wall.
In another embodiment the deactivating agent and explosive composition may be provided in separate (sealed) components that are coupled only when the cartridge is to be used.
Thus, the deactivating agent may be provided in a sealed cap that is adapted to be attached to a base cartridge portion including the explosive composition. The act of coupling the components together may cause release of the deactivating agent and this may be achieved along the lines already described. In this embodiment the cap containing the deactivating agent may need to be adapted to allow for a detonator to be inserted into the base cartridge portion. Additionally, a train of cartridges would need to be constructed with a cap containing the deactivating agent provided immediately above each base cartridge portion.
Construction of a train of individual explosive charges may be more onerous in this embodiment when compared with embodiments where the deactivating agent and explosive composition are provided in a single (cartridge) structure.
Irrespective of which particular embodiment is employed, the integrity of the barrier element will only be compromised when the detonator is being used in the field. Prior to that point in time the barrier element is intended to remain intact thereby separating the deactivating agent and explosive composition.
In the embodiments described, when breach or removal of the barrier element is instantaneous, the deactivating agent and explosive composition will come into contact with each other straightaway. In this case the deactivating agent will start acting upon the explosive composition immediately. However, in such embodiments for the explosive cartridge to have a period of usefulness, it is important that the deactivating agent does not render the explosive composition insensitive to detonation, or reduce significantly the energy output of the explosive composition, immediately. If it did, the explosive cartridge would be useless, or of little practical use, as soon as the deactivating agent is released from the chamber containing it. It is instead intended that the deactivating agent desensitises the explosive composition after a suitable period of time and by this is meant a period of time after which detonation should otherwise have occurred. Thus, after release of the deactivating agent, the explosive cartridge may need to remain fully detonable (with the energetic output of the explosive composition unaffected or substantially unaffected) for a period of up to a few weeks, preferably for a period of up to a few (e.g. three to six) months. In some instances the explosive cartridge may be required to remain detonable (and useful) for a longer period, for example up to about twelve months. The reaction kinetics associated with the deactivating agent and explosive composition will dictate the rate of which the explosive composition is desensitised. In practice to achieve a useful product the reaction is relatively slow so that the transition between the explosive composition being detonable and non-detonable may be a relatively long one.
7,077,044, the contents of which are incorporated by reference.
Typically, the external configuration of the explosive cartridge is cylindrical with the deactivating agent and explosive composition occupying respective chambers within the body of the cartridge. In this embodiment the explosive cartridge is invariably sealed so that there is no risk of escape of components, for example, during storage and/or transportation. Sealing may be achieved by conventional techniques depending upon the materials used to form the cartridge. If the cartridge is formed from plastic, the body of the cartridge, including the respective chambers of it, may be formed by injection moulding with the chambers of the cartridge being loaded with the deactivating agent and explosive composition as required, with subsequent sealing (heat sealing, for example) in order to seal the inlets through which these components are supplied into respective chambers in the body of the cartridge.
The cartridge may be made up of independent components that are adapted to be attached to each other as the cartridge is being loaded with respective components and when used in the field. By way of example, the explosive composition may be provided in a chamber that is adapted to be secured to another component comprising a chamber for the deactivating agent. The chamber for the deactivating agent may be of single piece construction, for example formed by injection moulding of a suitable plastics material, and include at least one detonator receiving channel as part of the construction.
The chamber for the deactivating agent may be provided as part of a cap well or lid piece for the chamber housing the explosive composition. The individual components may be attached to each other by any suitable mechanism, such as interference (friction) fit, male-female screw threading or clip fitting. In this case the explosive composition may be loaded into the respective chamber and the lid secured to the top of the explosive composition chamber. If the explosive composition is a fluid, the attachment must be such that loss of explosive composition is prevented. However, if the explosive composition is solid in nature, for example when the explosive composition is cast hot and allowed to solidify, the attachment may be loose fitting, and this may be beneficial in terms of allowing water to enter the cartridge, as will be explained. The cap well (lid piece) will also generally include a lid/seal over its open end, and this may also allow water to enter the cartridge.
As a further alternative, rather than relying on separate chambers that are integrally formed as parts of the cartridge structure, the deactivating agent and/or explosive composition may be provided in independent containers that are inserted into a rigid cartridge body. In this case it will be appreciated that the cartridge is made up of at least two independent parts and that in use the cartridge is assembled from those parts.
The material(s) used to form the cartridge of the invention should not be corroded by or be reactive towards the deactivating agent and explosive composition to be contained. Thus, the cartridge will retain its structural integrity.
In one embodiment the barrier element takes the form of an internal wall or internal wall portion (membrane) separating the chambers containing the deactivating agent and explosive composition. When this wall or wall portion is breached or removed the deactivating agent and explosive composition come into direct contact with each other. In accordance with the invention, this occurs only during use. Thus, in one embodiment the wall or wall portion may be ruptured by insertion of a detonator into the explosive cartridge (detonators are invariably used to initiate detonation), or by the act of connecting one cartridge to another to form a train of cartridges, as is common practice.
With respect to use of a detonator, the cartridge is usually adapted to receive the detonator in a suitably shaped passage extended axially within the body of the cartridge. The cartridge may be adapted to receive a single detonator or more than one detonator in respective, suitably shaped passages. In this regard it should be understood that explosive cartridges for use in seismic exploration, for example, generally allow inclusion of two detonators, a primary detonator and a secondary (back-up) detonator in case the primary detonator does not detonate as intended.
In the embodiment described above the barrier element may extend across this detonator-receiving passage such that, when the detonator is pushed into position in the cartridge, the wall originally separating the deactivating agent and explosive composition is ruptured thereby allowing these components to come into direct contact with each other.
Alternatively, the action of inserting the detonator into the cartridge may cause a separate component to rupture the wall. This component may be a needle-like structure, rigid tube, or similar.
To achieve release of the deactivating agent when cartridges are coupled together in a train, the lower end of the cartridge may include a suitably shaped extension for insertion into the detonator-receiving passage of an adjacent cartridge (of the same design).
Insertion of this extension into the detonator-receiving passage has the same effect as inserting a detonator in that the wall/membrane separating the deactivating agent and explosive composition is ruptured. Alternatively, the upper end of the cartridge may include a component that is adapted to be displaced downwardly (or upwardly) when the cartridges are coupled together and that causes the wall membrane to be ruptured. To facilitate attachment explosive cartridges in accordance with the present invention may also include suitable engagement or retaining means. For example, the lower end of the cartridge may include external threads with the upper end including corresponding internal threads thereby allowing adjacent cartridges to be secured to each other. It will be appreciated that the external shape of the lower end of the cartridge is adapted to mate with the upper end of an adjacent cartridge. In the particular embodiment described, the act of engaging and screwing cartridges together may cause rupture of the wall.
In another embodiment the deactivating agent and explosive composition may be provided in separate (sealed) components that are coupled only when the cartridge is to be used.
Thus, the deactivating agent may be provided in a sealed cap that is adapted to be attached to a base cartridge portion including the explosive composition. The act of coupling the components together may cause release of the deactivating agent and this may be achieved along the lines already described. In this embodiment the cap containing the deactivating agent may need to be adapted to allow for a detonator to be inserted into the base cartridge portion. Additionally, a train of cartridges would need to be constructed with a cap containing the deactivating agent provided immediately above each base cartridge portion.
Construction of a train of individual explosive charges may be more onerous in this embodiment when compared with embodiments where the deactivating agent and explosive composition are provided in a single (cartridge) structure.
Irrespective of which particular embodiment is employed, the integrity of the barrier element will only be compromised when the detonator is being used in the field. Prior to that point in time the barrier element is intended to remain intact thereby separating the deactivating agent and explosive composition.
In the embodiments described, when breach or removal of the barrier element is instantaneous, the deactivating agent and explosive composition will come into contact with each other straightaway. In this case the deactivating agent will start acting upon the explosive composition immediately. However, in such embodiments for the explosive cartridge to have a period of usefulness, it is important that the deactivating agent does not render the explosive composition insensitive to detonation, or reduce significantly the energy output of the explosive composition, immediately. If it did, the explosive cartridge would be useless, or of little practical use, as soon as the deactivating agent is released from the chamber containing it. It is instead intended that the deactivating agent desensitises the explosive composition after a suitable period of time and by this is meant a period of time after which detonation should otherwise have occurred. Thus, after release of the deactivating agent, the explosive cartridge may need to remain fully detonable (with the energetic output of the explosive composition unaffected or substantially unaffected) for a period of up to a few weeks, preferably for a period of up to a few (e.g. three to six) months. In some instances the explosive cartridge may be required to remain detonable (and useful) for a longer period, for example up to about twelve months. The reaction kinetics associated with the deactivating agent and explosive composition will dictate the rate of which the explosive composition is desensitised. In practice to achieve a useful product the reaction is relatively slow so that the transition between the explosive composition being detonable and non-detonable may be a relatively long one.
In other embodiments of the present invention the barrier element is adapted/designed to be breached or removed only after the explosive cartridge is used. In these embodiments removal/breach of the barrier element is not instantaneous on use of the cartridge, but rather some mechanism is activated that will lead to removal/breach of the barrier element after some predetermined period of time. Taking into account the activity of the deactivating agent this will invariably be a period of time after which desensitisation of the explosive composition is desired due to failure of the explosive cartridge to be detonated, as described above. The mechanism by which the barrier element is removed or breached may be chemical, electrical or mechanical in character.
In another embodiment of the invention the deactivating agent is provided separate to the explosive composition and must be mobilised in order for contact with the explosive composition to take place. In this case the deactivating agent may be provided in any suitable form that is rendered mobile by water that enters or is delivered into the explosive cartridge when used. Thus, the deactivating agent may be provided in dehydrated or dried form such that contact with water results in formation of a solution or suspension of deactivating agent in water. Formation of the solution or suspension renders the deactivating agent mobile. The deactivating agent may also be provided as a gel or viscous liquid that itself is not suitably mobile but that when contacted with water becomes mobile. Herein reference is made to water being used as the vehicle that renders the deactivating agent mobile. Other liquid vehicles may of course be used. Water tends to be convenient as it is generally present in environmental in which the explosive cartridge will be used.
A water-permeable membrane may be used to separate the explosive composition and deactivating agent with the deactivating agent permeating this membrane when mobilised by contact with water. In this regard the water-permeable membrane may be provided with one or more apertures to allow the (mobilised) deactivating agent to come into contact with the explosive composition. The same apertures may also allow water to come into contact with the deactivating agent in order to render it mobile. It may also be possible to implement this embodiment using a water-degradable membrane to separate the explosive composition and deactivating agent. In this case the deactivating agent may be provided in a water-degradable (or water-soluble) packet or wrapper, formed for example from polyvinyl alcohol. This may simplify design since in this case the encapsulated deactivating agent may simply be positioned on top of or within the bulk of the explosive composition. In these embodiments it is important that the membrane or packet/wrapper that is used is not degraded by the explosive composition.
In this embodiment the explosive cartridge may include one or more inlets (apertures) and/or water-degradable pathways to allow environmental water to flow into the cartridge and directly into contact with the deactivating agent. Additionally, or alternatively, the explosive cartridge may include one or more inlets (apertures) and/or water-degradable pathways to allow environmental water to flow into the cartridge and into contact with the deactivating agent through the explosive composition. In this case the explosive composition may include channels to allow water to migrate to the deactivating agent. The channels may be artificially formed in the explosive composition and/or be naturally occurring given the nature of the explosive composition and the manner in which the explosive composition is loaded into the explosive cartridge. With respect to the latter case, if the explosive composition is delivered into the respective chamber above its melting point and is allowed to solidify subsequently, a network of cracks and fissures may be formed in the solidified form of the explosive composition. Water may migrate through these cracks and fissures. In this embodiment water must obviously be able to enter the explosive composition in the first place, and ways in which this can be achieved are described herein. When a water-permeable or water-degradable membrane is used to separate the explosive composition and deactivating agent, the membrane may define a cavity or cavities that separate(s) the deactivating agent and explosive composition with environmental water entering these cavities when the explosive cartridge is used. As a further variation, water may be supplied into the explosive cartridge immediately prior to use. For example, an explosive cartridge could be suitably submerged in water prior to being positioned in a blasthole or the like, so that the water enters the explosive cartridge as desired. Water may also be delivered into the explosive cartridge through a feed line.
In another embodiment of the invention the deactivating agent is provided separate to the explosive composition and must be mobilised in order for contact with the explosive composition to take place. In this case the deactivating agent may be provided in any suitable form that is rendered mobile by water that enters or is delivered into the explosive cartridge when used. Thus, the deactivating agent may be provided in dehydrated or dried form such that contact with water results in formation of a solution or suspension of deactivating agent in water. Formation of the solution or suspension renders the deactivating agent mobile. The deactivating agent may also be provided as a gel or viscous liquid that itself is not suitably mobile but that when contacted with water becomes mobile. Herein reference is made to water being used as the vehicle that renders the deactivating agent mobile. Other liquid vehicles may of course be used. Water tends to be convenient as it is generally present in environmental in which the explosive cartridge will be used.
A water-permeable membrane may be used to separate the explosive composition and deactivating agent with the deactivating agent permeating this membrane when mobilised by contact with water. In this regard the water-permeable membrane may be provided with one or more apertures to allow the (mobilised) deactivating agent to come into contact with the explosive composition. The same apertures may also allow water to come into contact with the deactivating agent in order to render it mobile. It may also be possible to implement this embodiment using a water-degradable membrane to separate the explosive composition and deactivating agent. In this case the deactivating agent may be provided in a water-degradable (or water-soluble) packet or wrapper, formed for example from polyvinyl alcohol. This may simplify design since in this case the encapsulated deactivating agent may simply be positioned on top of or within the bulk of the explosive composition. In these embodiments it is important that the membrane or packet/wrapper that is used is not degraded by the explosive composition.
In this embodiment the explosive cartridge may include one or more inlets (apertures) and/or water-degradable pathways to allow environmental water to flow into the cartridge and directly into contact with the deactivating agent. Additionally, or alternatively, the explosive cartridge may include one or more inlets (apertures) and/or water-degradable pathways to allow environmental water to flow into the cartridge and into contact with the deactivating agent through the explosive composition. In this case the explosive composition may include channels to allow water to migrate to the deactivating agent. The channels may be artificially formed in the explosive composition and/or be naturally occurring given the nature of the explosive composition and the manner in which the explosive composition is loaded into the explosive cartridge. With respect to the latter case, if the explosive composition is delivered into the respective chamber above its melting point and is allowed to solidify subsequently, a network of cracks and fissures may be formed in the solidified form of the explosive composition. Water may migrate through these cracks and fissures. In this embodiment water must obviously be able to enter the explosive composition in the first place, and ways in which this can be achieved are described herein. When a water-permeable or water-degradable membrane is used to separate the explosive composition and deactivating agent, the membrane may define a cavity or cavities that separate(s) the deactivating agent and explosive composition with environmental water entering these cavities when the explosive cartridge is used. As a further variation, water may be supplied into the explosive cartridge immediately prior to use. For example, an explosive cartridge could be suitably submerged in water prior to being positioned in a blasthole or the like, so that the water enters the explosive cartridge as desired. Water may also be delivered into the explosive cartridge through a feed line.
In another related embodiment water or some other suitable solution may be contained in a membrane within the shell of the cartridge and/or the explosive composition, with the membrane releasing the water/solution after some predetermined time.
In a further embodiment the deactivating agent may be provided in contact with the explosive composition, for example the deactivating agent may be distributed through the bulk of the explosive composition. In this embodiment the deactivating agent may be encapsulated or provided in pelletised or granulated form, or the like. This general approach is known in the art in relation to the use of microorganisms as deactivating agent, for example from US 6,334,395 and US 6,668,725.
This embodiment also relies on the need for the deactivating agent to be in contact with water so that it is in a form that will effect desensitisation and/or so that it is in a form suitably mobile to effect desensitisation. As noted above the explosive cartridge may include one or more inlets or water-degradable pathways to allow the introduction of water into the body of the cartridge. Water may be conveyed to, and possibly through the bulk of, the explosive composition by use of a suitably designed water-permeable or water-degradable membrane. The explosive composition may be housed in a chamber (shell) the outer walls of which are formed from a water-permeable cardboard or plastics-based material. When the explosive composition is a solid, such as cast Pentolite, in principle it may be possible to dispose of any outer shell.. However, the end of the explosive cartridge may then require a rigid end cap or similar housing to facilitate loading of the cartridge into a blasthole.
In an embodiment of the present invention the explosive composition is deactivated by the combined activity of the deactivating agent as described herein and an additional deactivating agent that enters the explosive cartridge during use thereof. For example, the additional deactivating agent may be at least one microorganism that is present in the environment in which the explosive cartridge is being used and that is capable of acting on the explosive composition in order to convert it into by-products that are at least less detonable, and preferably non-detonable, when compared with the explosive composition in its original form in the explosive cartridge.
In an embodiment of the invention the additional deactivating agent acts on the explosive composition to render it more environmentally friendly (non-toxic), as might be useful in practice.
In this embodiment the at least one microorganism may be carried into the explosive cartridge in water present in the surroundings in which the cartridge is positioned (blastholes are typically wet environments). The cartridge may be designed to include apertures or inlets to allow ingress of environmental water, and thus microorganisms, into the body of the cartridge and into contact with the explosive composition.
Channels may be provided in and/or around the explosive composition to ensure a suitably high surface area of contact between incoming water/microorganisms and the explosive composition.
In one embodiment the cartridge may include a water-permeable or water-degradable outer shell (membrane) surrounding the explosive composition, possibly with channels or passages extending into the explosive composition. In use water permeates or degrades the shell (and channels/passages when present) thereby allowing the water and microorganisms to come into contact with the explosive composition. At that time the microorganisms begin to act on the explosive composition as intended.
In another related embodiment the cartridge includes a shell and optionally channels/passages formed of a material that will be dissolved by water and/or consumed by microorganisms present in the environment in which the cartridge is used. In this embodiment the microorganisms also have the ability to act on the explosive composition as described above. Desirably the microorganisms have a greater affinity for the material of the shell (and where present channels/passages) so that once the material is breached the microorganism acts on the explosive composition.
In these embodiments the time taken for the microorganism to.come into contact with the explosive composition and the rate at which the microorganism acts on the explosive composition as desired (under prevailing conditions of use) is such that deactivation of the cartridge will not be achieved until a predetermined amount of time has elapsed, prior to which the cartridge would normally have been detonated.
The explosive composition used in the explosive cartridge of the invention is conventional in nature and will be selected based on its ability to be desensitised by the deactivation agent or agents to be used. Examples of explosive materials that may be considered for use in the present invention include trinitrotoluene (TNT), pentaerythritol tetranitrate (PETN), cyclotrimethylene trinitramine (RDX) and cyclotetramethylene tetranitramine (HMX). The explosive composition may be an emulsion explosive, a water-gel explosive or an ANFO or other nitrate-based composition. Other less conventional explosives may also be used such as liquid or gel compositions which are aqueous or non-aqueous and possible containing other explosive components such as perchlorates.
Combinations of explosive materials may also be used. For example, the explosive composition may be Pentolite, a mixture of PETN and TNT. The explosive composition may also contain other explosive and/or reactive ingredients, such as RDX and metallic (e.g.
aluminium) particles.
In one embodiment of the present invention the explosive composition may be a water-in-oil emulsion. Emulsion explosive compositions typically includes a discontinuous phase comprising a supersaturated aqueous solution of an oxidiser salt (usually ammonium nitrate) dispersed in a continuous oil (fuel) phase. Such emulsions are usually formed by mixing the components in the presence of a suitable emulsifier. In the context of emulsion explosive compositions, the deactivating agent may include any reagent that is capable of breaking or rendering unstable the emulsion, thereby causing it to be insensitive to detonation. Usually, the deactivating agent will have the effect of causing crystallisation of the supersaturated emulsion component (the oxidiser salt in the type of emulsions described). Accordingly, one skilled in the art may select suitable reagents for use as deactivating agent, at least for initial screening, based on a general knowledge of emulsion chemistry and of reagents that are known to cause unwanted crystallisation of (supersaturated) emulsion explosive compositions. Here it is important to note that the present invention seeks to make positive use of reagents that might previously have been regarded as being detrimental in the context of emulsion explosive compositions. The type of deactivating agent used will usually be selected on the basis of the emulsion explosive composition being used rather than vice versa.
The present invention has particular utility in seismic survey applications and in this case the explosive cartridge takes the form of a seismic charge. One skilled in the art will be familiar with the type of explosives in this context.
Embodiments of the present invention are illustrated in the accompanying non-limiting figures, in which:
Figures 1-3 shows a cross-section of explosive cartridges in accordance with the present invention, with Figures 2 and 3 illustrating the same design;
Figures 4 and 5 are perspective views of explosive cartridges in accordance with the present invention;
Figure 6 is a cross-section of an explosives cartridge in accordance with the present invention; and Figures 7 and 8 are perspective views showing a component of the explosives cartridge depicted in Figure 6.
Thus, Figure 1 shows an explosive cartridge (1) suitable for use in seismic exploration.
The explosive composition and deactivating agent remain sealed in their respective chambers (2, 3). Therefore, subject to the stability of the emulsion explosive composition, the cartridge (1) is a storage stable product.
The cartridge also includes a small diameter axial channel (4) extending down within the body of the cartridge (1) from the deactivating agent chamber (3) through the explosive composition. This channel (4) is defined by a wall formed from a polymeric material that is degradable on contact with the deactivating agent. In the arrangement shown in Figure 1 the channel (4) is empty since the deactivating agent has not been released from the chamber (3). A seal (not shown in detail) is provided between the deactivating agent chamber (3) and the channel (4), this seal being designed so that breakage of it will cause release of deactivating agent from chamber (3) into channel (4) extending through the explosive composition.
The upper end of the cartridge (1) is adapted to receive a cylindrical detonator (5). When the cartridge (1) is to be used in the field, this detonator (5) is inserted into a detonator-receiving channel (6) extending into the body of the cartridge (1). In the embodiment shown the detonator-receiving channel (6) is provided as an extension of the channel (4).
The action of inserting the detonator into the detonator-receiving channel (6) causes the seal between the deactivating agent chamber (3) and the channel (4) to be broken thereby releasing deactivating agent into the channel (4). However, contact between the deactivating agent and the explosive composition is prevented by the walls of the channel (4) and the deactivating agent must first penetrate these walls before contacting explosive composition.
Although not shown, it may be necessary for the design to include some kind of air inlet (or breather tube) to allow air into the deactivating agent chamber (3) as deactivating agent flows out. In the absence of an air inlet, flow of deactivating agent may be restricted.
Generally, air will only be allowed into the deactivating agent chamber (3) when the cartridge is being used, thereby preventing leakage of the deactivating agent.
Surface tension effects of the deactivating agent may also influence design or the characteristics of the deactivating agent to be used. Although also not shown it may be useful to allow the deactivating agent once released to come into contact with a wick or open cell foam that extends down into the channel (4) and that has the effect of conducting/drawing deactivating agent down into the channel (4).
The walls of the channel (4) are made of a degradable (polymeric) material that may be hydrolysed by water present in the aqueous deactivating agent. On contact of the deactivating agent and the walls of the channel (4) the deactivating agent therefore (slowly) degrades the walls. Whilst the walls remain intact no contact of the deactivating agent and explosive composition takes place and this delay allows a user of the cartridge (1) sufficient time to load the cartridge into a blasthole and attempt detonation of the cartridge (1) as intended. Thus, the functionality of the cartridge (1) remains intact even though the deactivating agent has been released from the chamber (3) originally containing it.
After a predetermined period of time (usually selected to be a number of months) the walls of the channel (4) will have been dissolved/consumed/weakened by the deactivating agent.
The integrity of the walls is therefore lost and the deactivating agent comes into contact with the explosive composition.
Although not shown in Figure 1 the lower end of the cartridge (1) may also be shaped in order to be inserted into the detonator-receiving channel of an adjacent cartridge. Thus, forming like cartridges into a train of cartridges can also result in release of deactivating agent from the chamber (3) in which it is originally contained. The upper and lower ends of the cartridge (1) may also contain cooperating features, such as screw threads, to enable cartridges to be secured together.
In the embodiment described when released the deactivating agent flows into channel (4) running essentially the entire length of the explosive composition included in the cartridge (1). This is a preferred arrangement and the volume of the cavity is configured to be such that in use it will contain sufficient deactivating agent to deactivate the entirety of the explosive composition (over time). After the wall of the channel (4) has been broken down by action of the deactivating agent, explosive composition adjacent to the deactivating agent and thus adjacent to the detonator when positioned in the cartridge will be first exposed to the deactivating agent. This region of the explosive composition therefore comes into contact with the highest concentration of deactivating agent thereby promoting the fastest and most effective deactivation of the explosive composition. Other arrangements are of course possible.
In an alternative arrangement the deactivating agent flows into an annular cavity provided in the outer periphery of the cartridge body. In this embodiment it will be appreciated that the degradable material is provided on the outer surface of the emulsion preventing contact between the explosive composition and the deactivating agent (when released).
When the material is degraded by the deactivating agent, the deactivating agent will contact outer regions of the explosive charge first. However, assuming the cartridge is used with a detonator in a central detonator-receiving passage, this embodiment suffers the potential drawback that explosive composition far removed from the location of the detonator will be deactivatedfirst. There is therefore a greater risk of failure to deactivate the explosive composition if the deactivating agent action does not penetrate radially into the explosive composition (towards the location of the detonator). This embodiment does however have the advantage of a high surface area of contact between the deactivating agent and explosive composition.
As a further alternative, the deactivating agent may flow into a cavity provided over the top of the body of explosive composition provided in the cartridge. However, this embodiment suffers the potential disadvantage of low surface area of contact between the deactivating agent and explosive composition and this can lead to slow and/or incomplete deactivation of the explosive composition. Other alternatives are of course possible within the context of the present invention.
Figures 2 and 3 illustrate another embodiment of the present invention. Figure 2 illustrates an arrangement before release of the deactivating agent and Figure 3 an arrangement when the deactivating agent is released. The Figures show an exploded view of only a portion of the cartridge.
Figures 2 and 3 show an explosive cartridge (1) in the form of an elongate cylinder made of a suitably rigid plastic. The cartridge includes a sealed chamber (2) containing an explosive composition and a further sealed chamber (3) containing a deactivating agent.
In a further embodiment the deactivating agent may be provided in contact with the explosive composition, for example the deactivating agent may be distributed through the bulk of the explosive composition. In this embodiment the deactivating agent may be encapsulated or provided in pelletised or granulated form, or the like. This general approach is known in the art in relation to the use of microorganisms as deactivating agent, for example from US 6,334,395 and US 6,668,725.
This embodiment also relies on the need for the deactivating agent to be in contact with water so that it is in a form that will effect desensitisation and/or so that it is in a form suitably mobile to effect desensitisation. As noted above the explosive cartridge may include one or more inlets or water-degradable pathways to allow the introduction of water into the body of the cartridge. Water may be conveyed to, and possibly through the bulk of, the explosive composition by use of a suitably designed water-permeable or water-degradable membrane. The explosive composition may be housed in a chamber (shell) the outer walls of which are formed from a water-permeable cardboard or plastics-based material. When the explosive composition is a solid, such as cast Pentolite, in principle it may be possible to dispose of any outer shell.. However, the end of the explosive cartridge may then require a rigid end cap or similar housing to facilitate loading of the cartridge into a blasthole.
In an embodiment of the present invention the explosive composition is deactivated by the combined activity of the deactivating agent as described herein and an additional deactivating agent that enters the explosive cartridge during use thereof. For example, the additional deactivating agent may be at least one microorganism that is present in the environment in which the explosive cartridge is being used and that is capable of acting on the explosive composition in order to convert it into by-products that are at least less detonable, and preferably non-detonable, when compared with the explosive composition in its original form in the explosive cartridge.
In an embodiment of the invention the additional deactivating agent acts on the explosive composition to render it more environmentally friendly (non-toxic), as might be useful in practice.
In this embodiment the at least one microorganism may be carried into the explosive cartridge in water present in the surroundings in which the cartridge is positioned (blastholes are typically wet environments). The cartridge may be designed to include apertures or inlets to allow ingress of environmental water, and thus microorganisms, into the body of the cartridge and into contact with the explosive composition.
Channels may be provided in and/or around the explosive composition to ensure a suitably high surface area of contact between incoming water/microorganisms and the explosive composition.
In one embodiment the cartridge may include a water-permeable or water-degradable outer shell (membrane) surrounding the explosive composition, possibly with channels or passages extending into the explosive composition. In use water permeates or degrades the shell (and channels/passages when present) thereby allowing the water and microorganisms to come into contact with the explosive composition. At that time the microorganisms begin to act on the explosive composition as intended.
In another related embodiment the cartridge includes a shell and optionally channels/passages formed of a material that will be dissolved by water and/or consumed by microorganisms present in the environment in which the cartridge is used. In this embodiment the microorganisms also have the ability to act on the explosive composition as described above. Desirably the microorganisms have a greater affinity for the material of the shell (and where present channels/passages) so that once the material is breached the microorganism acts on the explosive composition.
In these embodiments the time taken for the microorganism to.come into contact with the explosive composition and the rate at which the microorganism acts on the explosive composition as desired (under prevailing conditions of use) is such that deactivation of the cartridge will not be achieved until a predetermined amount of time has elapsed, prior to which the cartridge would normally have been detonated.
The explosive composition used in the explosive cartridge of the invention is conventional in nature and will be selected based on its ability to be desensitised by the deactivation agent or agents to be used. Examples of explosive materials that may be considered for use in the present invention include trinitrotoluene (TNT), pentaerythritol tetranitrate (PETN), cyclotrimethylene trinitramine (RDX) and cyclotetramethylene tetranitramine (HMX). The explosive composition may be an emulsion explosive, a water-gel explosive or an ANFO or other nitrate-based composition. Other less conventional explosives may also be used such as liquid or gel compositions which are aqueous or non-aqueous and possible containing other explosive components such as perchlorates.
Combinations of explosive materials may also be used. For example, the explosive composition may be Pentolite, a mixture of PETN and TNT. The explosive composition may also contain other explosive and/or reactive ingredients, such as RDX and metallic (e.g.
aluminium) particles.
In one embodiment of the present invention the explosive composition may be a water-in-oil emulsion. Emulsion explosive compositions typically includes a discontinuous phase comprising a supersaturated aqueous solution of an oxidiser salt (usually ammonium nitrate) dispersed in a continuous oil (fuel) phase. Such emulsions are usually formed by mixing the components in the presence of a suitable emulsifier. In the context of emulsion explosive compositions, the deactivating agent may include any reagent that is capable of breaking or rendering unstable the emulsion, thereby causing it to be insensitive to detonation. Usually, the deactivating agent will have the effect of causing crystallisation of the supersaturated emulsion component (the oxidiser salt in the type of emulsions described). Accordingly, one skilled in the art may select suitable reagents for use as deactivating agent, at least for initial screening, based on a general knowledge of emulsion chemistry and of reagents that are known to cause unwanted crystallisation of (supersaturated) emulsion explosive compositions. Here it is important to note that the present invention seeks to make positive use of reagents that might previously have been regarded as being detrimental in the context of emulsion explosive compositions. The type of deactivating agent used will usually be selected on the basis of the emulsion explosive composition being used rather than vice versa.
The present invention has particular utility in seismic survey applications and in this case the explosive cartridge takes the form of a seismic charge. One skilled in the art will be familiar with the type of explosives in this context.
Embodiments of the present invention are illustrated in the accompanying non-limiting figures, in which:
Figures 1-3 shows a cross-section of explosive cartridges in accordance with the present invention, with Figures 2 and 3 illustrating the same design;
Figures 4 and 5 are perspective views of explosive cartridges in accordance with the present invention;
Figure 6 is a cross-section of an explosives cartridge in accordance with the present invention; and Figures 7 and 8 are perspective views showing a component of the explosives cartridge depicted in Figure 6.
Thus, Figure 1 shows an explosive cartridge (1) suitable for use in seismic exploration.
The explosive composition and deactivating agent remain sealed in their respective chambers (2, 3). Therefore, subject to the stability of the emulsion explosive composition, the cartridge (1) is a storage stable product.
The cartridge also includes a small diameter axial channel (4) extending down within the body of the cartridge (1) from the deactivating agent chamber (3) through the explosive composition. This channel (4) is defined by a wall formed from a polymeric material that is degradable on contact with the deactivating agent. In the arrangement shown in Figure 1 the channel (4) is empty since the deactivating agent has not been released from the chamber (3). A seal (not shown in detail) is provided between the deactivating agent chamber (3) and the channel (4), this seal being designed so that breakage of it will cause release of deactivating agent from chamber (3) into channel (4) extending through the explosive composition.
The upper end of the cartridge (1) is adapted to receive a cylindrical detonator (5). When the cartridge (1) is to be used in the field, this detonator (5) is inserted into a detonator-receiving channel (6) extending into the body of the cartridge (1). In the embodiment shown the detonator-receiving channel (6) is provided as an extension of the channel (4).
The action of inserting the detonator into the detonator-receiving channel (6) causes the seal between the deactivating agent chamber (3) and the channel (4) to be broken thereby releasing deactivating agent into the channel (4). However, contact between the deactivating agent and the explosive composition is prevented by the walls of the channel (4) and the deactivating agent must first penetrate these walls before contacting explosive composition.
Although not shown, it may be necessary for the design to include some kind of air inlet (or breather tube) to allow air into the deactivating agent chamber (3) as deactivating agent flows out. In the absence of an air inlet, flow of deactivating agent may be restricted.
Generally, air will only be allowed into the deactivating agent chamber (3) when the cartridge is being used, thereby preventing leakage of the deactivating agent.
Surface tension effects of the deactivating agent may also influence design or the characteristics of the deactivating agent to be used. Although also not shown it may be useful to allow the deactivating agent once released to come into contact with a wick or open cell foam that extends down into the channel (4) and that has the effect of conducting/drawing deactivating agent down into the channel (4).
The walls of the channel (4) are made of a degradable (polymeric) material that may be hydrolysed by water present in the aqueous deactivating agent. On contact of the deactivating agent and the walls of the channel (4) the deactivating agent therefore (slowly) degrades the walls. Whilst the walls remain intact no contact of the deactivating agent and explosive composition takes place and this delay allows a user of the cartridge (1) sufficient time to load the cartridge into a blasthole and attempt detonation of the cartridge (1) as intended. Thus, the functionality of the cartridge (1) remains intact even though the deactivating agent has been released from the chamber (3) originally containing it.
After a predetermined period of time (usually selected to be a number of months) the walls of the channel (4) will have been dissolved/consumed/weakened by the deactivating agent.
The integrity of the walls is therefore lost and the deactivating agent comes into contact with the explosive composition.
Although not shown in Figure 1 the lower end of the cartridge (1) may also be shaped in order to be inserted into the detonator-receiving channel of an adjacent cartridge. Thus, forming like cartridges into a train of cartridges can also result in release of deactivating agent from the chamber (3) in which it is originally contained. The upper and lower ends of the cartridge (1) may also contain cooperating features, such as screw threads, to enable cartridges to be secured together.
In the embodiment described when released the deactivating agent flows into channel (4) running essentially the entire length of the explosive composition included in the cartridge (1). This is a preferred arrangement and the volume of the cavity is configured to be such that in use it will contain sufficient deactivating agent to deactivate the entirety of the explosive composition (over time). After the wall of the channel (4) has been broken down by action of the deactivating agent, explosive composition adjacent to the deactivating agent and thus adjacent to the detonator when positioned in the cartridge will be first exposed to the deactivating agent. This region of the explosive composition therefore comes into contact with the highest concentration of deactivating agent thereby promoting the fastest and most effective deactivation of the explosive composition. Other arrangements are of course possible.
In an alternative arrangement the deactivating agent flows into an annular cavity provided in the outer periphery of the cartridge body. In this embodiment it will be appreciated that the degradable material is provided on the outer surface of the emulsion preventing contact between the explosive composition and the deactivating agent (when released).
When the material is degraded by the deactivating agent, the deactivating agent will contact outer regions of the explosive charge first. However, assuming the cartridge is used with a detonator in a central detonator-receiving passage, this embodiment suffers the potential drawback that explosive composition far removed from the location of the detonator will be deactivatedfirst. There is therefore a greater risk of failure to deactivate the explosive composition if the deactivating agent action does not penetrate radially into the explosive composition (towards the location of the detonator). This embodiment does however have the advantage of a high surface area of contact between the deactivating agent and explosive composition.
As a further alternative, the deactivating agent may flow into a cavity provided over the top of the body of explosive composition provided in the cartridge. However, this embodiment suffers the potential disadvantage of low surface area of contact between the deactivating agent and explosive composition and this can lead to slow and/or incomplete deactivation of the explosive composition. Other alternatives are of course possible within the context of the present invention.
Figures 2 and 3 illustrate another embodiment of the present invention. Figure 2 illustrates an arrangement before release of the deactivating agent and Figure 3 an arrangement when the deactivating agent is released. The Figures show an exploded view of only a portion of the cartridge.
Figures 2 and 3 show an explosive cartridge (1) in the form of an elongate cylinder made of a suitably rigid plastic. The cartridge includes a sealed chamber (2) containing an explosive composition and a further sealed chamber (3) containing a deactivating agent.
During storage and transport of the cartridge (1) the deactivating agent and explosive composition remain sealed in their respective chamber (2,3).
The cartridge (1) also includes a small diameter axial channel (4) extending down within the body of the cartridge (1) from the deactivating agent chamber (3) through the explosive composition. This channel is provided off-centre and is distinct from the channel into which a detonator (5) is provided. The walls of the channel (4) may be formed of a porous material that in use will allow deactivating agent to be communicated to the explosive composition and that has sufficient structural rigidity to define a channel adjacent or through the explosive composition.
At the top (entrance) to the channel (4) there is an arrangement that is designed to cause release of deactivating agent from chamber (3) into the channel (4) when the cartridge (1) is to be used. This arrangement includes an elongate element (7) projecting upwardly from the top of the channel (4). This element (7) may be a tube that is adapted at one end to pierce a correspondingly located (rubber) seal (8) provided on the lower end of the deactivating agent chamber (3). The element (7) communicates at its lower end with a seal (9) provided over the entrance to the channel (4). This seal (9) is made of a material that is degradable on contact with the deactivating agent.
Prior to use the seal (8) is in tact and the seal (8) and element (7) are in close proximity to each other. This arrangement is shown in Figure 2. In use of the cartridge, the deactivating agent chamber (3) is displaced downwards relative to the element (7) and this occurs as a result of engagement of the upper end of the cartridge (1) with an engagement member (10). In the embodiment shown the inner surface of the upper end of the cartridge (1) includes screw threads adapted to engage corresponding screw threads provided on the outer surface of the engagement member (10). The member (10) may be a specially designed cartridge cap or the lower end of another cartridge (1). The action of screwing the member (10) into the top of the cartridge (1) causes the deactivating agent chamber (3) to be displaced downwards. In turn this causes the piercing element (7) to pierce the (rubber) seal (8). Deactivating agent then flows down through the element (7) thereby coming into contact with the degradable seal (9). This is shown in Figure 3.
As already noted, an air inlet or breather tube may be required to ensure flow of the deactivating agent, and surface tension effects may need to be taken into account too.
Preferably, the air inlet/breather tube is "activated" only when the member (10) is screwed into the top of the cartridge (1) in order to release the deactivating agent. This prevents leakage of deactivating agent prior to use.
After a predetermined period of time the seal (9) will be dissolved/consumed/weakened by the action of the deactivating agent. The integrity of the seal is lost thereby allowing deactivating agent to drain into the channel (4). The deactivating agent then flows through the porous/permeable walls of the channel and into contact with the explosive composition.
The deactivating agent goes on to desensitise the explosive composition thereby rendering it safe.
Figure 4 shows an explosive cartridge (1) useful in implementation of the invention. The cartridge 1 includes explosive composition (11) which typically is in a solid (cast) form, such as Pentolite (typically a PETN/TNT and/or RDX mix). The explosive composition 11 includes the detonator receiving channels (6) that enable the cartridge to be initiated by different sized (diameter) detonators. The cartridge (1) includes an outer shell (12) that is made of a water-permeable or water-degradable material. In the field environmental water will thus permeate or degrade the shell. The shell (12) also defines passages (13) extending into the explosive composition (11). The use of this configuration and type of shell allows environmental water to come into contact with the explosive composition (11), and is thus useful in embodiments of the invention where this is intended/required. The explosive composition (11) includes an enzyme-based deactivating agent. For example, the enzyme may be in contact with and/or distributed throughout the explosive composition (11) in the form of pellets or granules. the pellets/granules may be mixed with the explosives composition (11) before the composition (11) is poured (cast) into the outer shell (12). Additionally or alternatively the enzyme may be provided within the material making up the outer shell (12).
The cartridge (1) also includes a small diameter axial channel (4) extending down within the body of the cartridge (1) from the deactivating agent chamber (3) through the explosive composition. This channel is provided off-centre and is distinct from the channel into which a detonator (5) is provided. The walls of the channel (4) may be formed of a porous material that in use will allow deactivating agent to be communicated to the explosive composition and that has sufficient structural rigidity to define a channel adjacent or through the explosive composition.
At the top (entrance) to the channel (4) there is an arrangement that is designed to cause release of deactivating agent from chamber (3) into the channel (4) when the cartridge (1) is to be used. This arrangement includes an elongate element (7) projecting upwardly from the top of the channel (4). This element (7) may be a tube that is adapted at one end to pierce a correspondingly located (rubber) seal (8) provided on the lower end of the deactivating agent chamber (3). The element (7) communicates at its lower end with a seal (9) provided over the entrance to the channel (4). This seal (9) is made of a material that is degradable on contact with the deactivating agent.
Prior to use the seal (8) is in tact and the seal (8) and element (7) are in close proximity to each other. This arrangement is shown in Figure 2. In use of the cartridge, the deactivating agent chamber (3) is displaced downwards relative to the element (7) and this occurs as a result of engagement of the upper end of the cartridge (1) with an engagement member (10). In the embodiment shown the inner surface of the upper end of the cartridge (1) includes screw threads adapted to engage corresponding screw threads provided on the outer surface of the engagement member (10). The member (10) may be a specially designed cartridge cap or the lower end of another cartridge (1). The action of screwing the member (10) into the top of the cartridge (1) causes the deactivating agent chamber (3) to be displaced downwards. In turn this causes the piercing element (7) to pierce the (rubber) seal (8). Deactivating agent then flows down through the element (7) thereby coming into contact with the degradable seal (9). This is shown in Figure 3.
As already noted, an air inlet or breather tube may be required to ensure flow of the deactivating agent, and surface tension effects may need to be taken into account too.
Preferably, the air inlet/breather tube is "activated" only when the member (10) is screwed into the top of the cartridge (1) in order to release the deactivating agent. This prevents leakage of deactivating agent prior to use.
After a predetermined period of time the seal (9) will be dissolved/consumed/weakened by the action of the deactivating agent. The integrity of the seal is lost thereby allowing deactivating agent to drain into the channel (4). The deactivating agent then flows through the porous/permeable walls of the channel and into contact with the explosive composition.
The deactivating agent goes on to desensitise the explosive composition thereby rendering it safe.
Figure 4 shows an explosive cartridge (1) useful in implementation of the invention. The cartridge 1 includes explosive composition (11) which typically is in a solid (cast) form, such as Pentolite (typically a PETN/TNT and/or RDX mix). The explosive composition 11 includes the detonator receiving channels (6) that enable the cartridge to be initiated by different sized (diameter) detonators. The cartridge (1) includes an outer shell (12) that is made of a water-permeable or water-degradable material. In the field environmental water will thus permeate or degrade the shell. The shell (12) also defines passages (13) extending into the explosive composition (11). The use of this configuration and type of shell allows environmental water to come into contact with the explosive composition (11), and is thus useful in embodiments of the invention where this is intended/required. The explosive composition (11) includes an enzyme-based deactivating agent. For example, the enzyme may be in contact with and/or distributed throughout the explosive composition (11) in the form of pellets or granules. the pellets/granules may be mixed with the explosives composition (11) before the composition (11) is poured (cast) into the outer shell (12). Additionally or alternatively the enzyme may be provided within the material making up the outer shell (12).
Figure 5 shows another form of an explosive cartridge (1) useful in implementation of the invention. The cartridge 1 includes an explosive composition 11, such as a cast Pentolite explosive, surrounded by a shell (12). An enzyme as deactivating agent may be provided in the explosive composition as described above in relation to Figure 4. The shell 12 is water-permeable or water-degradable, as for the shell discussed in Figure 4.
In Figure 2 the shell 12 includes radial members 14 extending into the bulk of the explosive composition. The intention here is that when the cartridge 1 comes into contact with water, water dissolves the shell (12) so that water is conveyed into contact with and through the explosive composition, as required by certain embodiments of the invention described herein. The rate at which the shell (12) dissolves may be controlled by suitable selection of material used to form the shell (12).
The material making up the shell (12), passages 13 and/or radial members 14 may be formed of a material that may be degraded by the action of microorganisms. As the shell (12) is degraded this allows water present in the environment to contact the deactivating agent provided in the explosive composition (11) or shell (12). In turn this renders the deactivating agent suitably mobile and/or active so that the deactivating agent can commence desensitisation of the explosive composition. The microorganisms may also have the effect of acting on the explosive composition to convert it into less detonable or non-detonable by-products and/or by-products that are more environmentally friendly.
Figure 6 shows and explosive cartridge (1) suitable for use in seismic exploration. The cartridge (1) includes an explosive composition (a) and deactivating agent (b) in respective chambers (2,3). The chamber for the explosive composition (a) is in the form of a cylindrical shell comprising wall portions (2') sealed by a base (2"). The explosive composition (a) may be Pentolite, possibly in mixture with RDX and/or aluminium particles. The deactivating agent (b) may be a dishwasher detergent containing enzymes and alkaline salts that are capable of deactivating the explosive composition.
The explosive composition (a) and deactivating agent (b) are separated in their respective chambers by a base plate (14) that is loosely fitted at the lower end of the chamber (3) for the deactivating agent (b). The plate (14) may be formed of any suitable material such as a polyester or polycarbonate. The plate (14) may be provided with a double-sided adhesive to allow it to be positioned and retained in place - the purpose of the plate is to prevent contact between the deactivating agent (a) and explosive composition (b). That said, depending upon the nature of the deactivating agent and explosive composition it may be possible to dispense with the plate (14) altogether.
The cartridge (1) also includes two detonator receiving channels (5') extending into the explosive composition (a). The cartridge (1) also includes a cap (15) at one end. This cap (15) is sized and shaped to fit, for example by interference fit, into the shell housing the explosive composition.
In practice the cartridge (1) may be provided as separate components that are assembled during loading of respective components and when used in the field. With respect to Figure 6, one component may be integrally formed (by injection moulding of a plastics material) to include and define, the cap (15), the detonator receiving channels (5') and the chamber (3) for the deactivating agent (b) as illustrated in Figures 7 and 8.
The base plate (14) and chamber/shell (2) for the explosive composition (a) are separate components. The chamber (2) is made up of a cylindrical tube comprising wall portions (2') and a base (2") that is attached at a lower end of the tube thereby sealing it.
Figures 7 and 8 illustrate certain components shown in Figure 6. Thus, Figures 7 and 8 show the cap (15), detonating receiving channels (5') and chamber (3) for the deactivating agent formed as a one-piece construction, for example by injection moulding of a suitable plastics material. The chamber (3) for the deactivating agent is sealed by a separate plate (14). The cap (15) comprises a circular wall portion (15a) with a lip (15b) that enables the cap (15) to be secured (by interference fit) into a suitably sized and shaped chamber in which an explosive composition is provided (not shown in Figures 7 and 8). The cap (15) is typically inserted into a tube forming. The wall portions (2') extend above and below the cap (15) once inserted and are adapted to allow attachment of other cartridges or a nose cone, for example by thread fitting. The internal surface of the wall portion (2') may include a lug or tab to engage the lip (15b) so as to maintain the cap (15) in position. The upper end of the cap (15) is open to allow for insertion of at least one detonator into respective detonator receiving channels (5'). The end of the cap (15c) may be sealed with a suitably sized and shaped lid (not shown) or be formed in an injection moulding process.
The cap (15) and/or wall portions (2') may include apertures to allow water to enter the explosive cartridge. As noted the wall portion (2') extending above the position of the cap (15) may receive the lower end of another explosive cartridge to form a train of cartridges.
In this regard a surface (15c) of the wall portion (2') may be threaded to mate with corresponding threads provided on the outer surface and at the base of another cartridge.
Cartridges may also be coupled by interference fit or by clip fasteners. The cap (15) may include apertures or grooves (not shown) in the side wall thereof extending through the circular wall portion (15a) and lip (15b) through which detonator leads may be passed after a detonator loading.
The embodiment illustrated in Figures 6-8 may be implemented as follows. In the orientation shown in Figure 8 the plate (14) is removed and deactivating agent inserted into the chamber (3). The plate (14) is then replaced thereby sealing the chamber (3). The seal is loose in the sense that the chamber (3) is not liquid tight. Still in the orientation shown in Figure 8, a cylindrical tube defining the wall portions (2') of the chamber (2) for the explosive composition (a) is inserted over the cap (15) with the cap (15) being retained in place by interference fit between the wall portion (2') and cap lip (15b).
An explosive composition, such as Pentolite, can then be poured into the open end of the tube, thereby surrounding the chamber (3) and detonator receiving channels (5'). If Pentolite is used it is cast above its melting point and allowed to solidify.
Solidification may result in the formation of cracks and fissures extending through the bulk of the explosive composition. This may be desirable as such cracks and fissures allow water to travel through the explosive composition, as may be desired. Once the tube has been suitably filled with explosive composition, and the composition solidified as might be necessary, a base (2") is attached to the open end of the tube. The base (2") and wall portions (2') may form a seal by interference fit, male-female screw threading or by clip fastening.
In use the component so-formed is loaded with one or more detonators with the detonator leads being passed out of the cap (15) or upper part of wall portions (2') as noted. The top end of the cap (15) may itself be sealed using a lid made of water-degradable material (not shown).
In the embodiment described it is intended that the deactivating agent is rendered mobile by water entering the chamber (3) around the edges of the plate (14). The plate may additionally or alternatively include apertures to allow water entry into the chamber (3).
Additionally or alternatively, the wall portions of the chamber (3) may also include structures to allow water to enter the chamber (3) (the chamber (3) may itself be made of water-degradable material to facilitate water ingress). Water mobilises the deactivating agent and the mobilised deactivating agent may exit the chamber (3) for contact with explosive composition via the same (or different) route through which water entered the chamber (3).
Water may find its way into the chamber (3) in one or a combination of more than one way, as follows.
Where respective components are joined together, for example the wall portions (2') forming the chamber (2) and the cap (15) or the wall portions (2') and base (2"), the joint may allow water ingress. In this case water would enter the chamber (3) around the plate (14) by migration through the bulk of the explosive composition. The composition must therefore allow water transport by the presence of artificial and/or intrinsic water transport structures.
Additionally or alternatively, water may enter the explosive composition through the walls (2') and/or base (2") of the chamber (2). One or both of these components may include channels/apertures to allow water entry and/or one or both may be water-permeable or water-degradable. The exact configuration will depend upon the form of, and thus the containment needs, of the explosive composition.
Additionally or alternatively, water may enter the chamber (3) via the cap (15). Thus, the cap (15) may include channels/apertures extending through the cap (15) and into the chamber (3), for example through an aperture between the inner surface (15c) and the chamber (3). The aperture may itself be sealed by a water-degradable material.
Water may enter the cap (15) through loose fitting seals (between the cap (15) and cap lid or between the wall portion (2') and an adjacent cartridge when a train of multiple cartridges is assembled). The apertures/grooves for the detonator leads may also allow water to enter the cap. Apertures/grooves in the upper part of the wall portions (2') may also allow water ingress.
One or more components of the cartridge may be water-degradable, and the degradability may be selective in order to provide enhanced control with respect to intended deactivation of the explosive composition.
Irrespective of the way in which water enters the chamber (3), when the deactivating agent is mobilised it will exit the chamber (3) and contact the explosive composition, thereby commencing deactivation of the explosive composition.
Embodiments of the present invention are illustrated in the following non-limiting example.
Example 1 500 ml of water was heated to 45 C in a water bath. Pentolite was added to 200ppm (200mg/L), consisting of 70ppm PETN and 130ppm TNT. Deactivating agent (in the form of commercially available detergent) at the recommended dose rate and at 10 x the recommended dose rate was added as noted in Table 1 below. The resultant solution was then removed from the water bath and allowed to sit at room temperature (21 C) overnight in the dark. Samples were taken and analysed for PETN and TNT. The experiment was repeated using sodium hydroxide and water as controls. The results are presented in Table 1 below. Table 2 below provides a list of ingredients as declared in relevant Material Safety Data Sheets (MSDSs) for the detergents used in the experiments.
Table 1 Reagent Dose (g/L) PETN (mg/L) TNT (mg/
Biozet (standard dose) 0.417 45 83 Cold Power concentrate (standard dose) 1.67 43 54 Cold Power rainforest (standard dose) 1.67 41 66 Drive concentrate (standard dose) 1.75 49 62 Duo matic (standard dose) 3.5 50 24 Dynamo matic (standard dose) 3.6 43 43 Fab concentrate (standard dose) 1.5 43 53 Finish Powerball 3 in I (standard dose) 2.1 40 45 Finish Powerball 5 in 1 (standard dose) 2.1 34 56 Home Brand 3 in 1 (standard dose) 2.05 37 43 Morning Fresh 5 in 1 (standard dose) 1.82 43 75 Napisan Plus (standard dose) 4 48 0.2 Omo matic (standard dose) 3.17 38 35 Radiant Micro concentrate (standard dose) 0.7 38 88 Radiant Power concentrate (standard dose) 1.58 34 32 Woolworths dishwasher tablets 5 in 1 (standard dose) 2.14 37 37 Woolworths laundry powder Advanced (standard dose) 1.17 46 64 Woolworths laundry powder Front Loader (standard dose) 2.33 39 40 Spree concentrate Apple Fresh (standard dose) 1.67 45 35 Squeek 4 in 1 (standard dose) 1.1 43 14 Surf Tropical (standard dose) 1.5 48 64 Biozet (I Ox dose) 4.17 41 11 Cold Power concentrate (l Ox dose) 16.7 51 3.2 Cold Power rainforest (l Ox dose) 16.7 48 8.5 Drive concentrate (l Ox dose) 17.5 48 13 Duo matic (I Ox dose) 35 52 0.2 Dynamo matic (I Ox dose) 36 4.4 0.5 Fab concentrate (l Ox dose) 15 40 4.7 Finish Powerball 3 in I (lOx dose) 21 32 0.4 Finish Powerball 5 in I (lOx dose) 21 32 1.3 Home Brand 3 in I (l Ox dose) 20.5 24 <0.1 Morning Fresh 5 in 1 (l Ox dose) 18.2 29 5.7 Napisan Plus (l Ox dose) 40 51 <0.1 Omo matic (l Ox dose) 31.7 45 2.8 Radiant Micro concentrate (l Ox dose) 7 40 36 Radiant Power concentrate (l Ox dose) 15.8 39 0.5 Woolworths dishwasher tablets 5 in 1 (l Ox dose) 21.4 17 <0.1 Woolworths laundry powder Advanced (1 Ox dose) 11.7 42 25 Woolworths laundry powder Front Loader (l Ox dose) 23.3 28 21 Spree concentrate Apple Fresh (l Ox dose) 16.7 31 0.7 Squeek 4 in I (l Ox dose) 11 16 <0.1 Surf Tropical (1 Ox dose) 15 21 6.8 Control - 45 110 0.004 M NaOH control 0.167 40 1.0 Table 2 Detergent Ingredients (as per MSDS) Name Proportion Biozet No information as yet Pentasodium triphosphate 10 - 30 Sodium sulphate 10 - 30 Sodium carbonate 10 - 30 Cold Power Sodium tridecyl benzene 0-10 concentrate sulphonate (linear) Sodium silicate 0-5 Sodium silicoaluminate 0-5 Non-haz ingredients to 100 Sodium sulphate 30 - 60 Pentasodium triphosphate 10-30 Cold Power Sodium silicate 1-10 rainforest Tetrasodium pyrophosphate 0-1 Sodium hydroxide 0 - 0.1 Non-haz ingredients to 100 Alkaline salts 10-30 Drive concentrate Anionic surfactants 10-30 Enzymes 0-10 Non-haz ingredients to 100 Sodium tripolyphosphate Proportions not supplied Duo matic Sodium xylene sulphonate Dodecyl benzene sulphonate Sodium carbonate 10 - 30 Ethoxylated C 12 - C 15 alchohol 0-5 Dynamo matic Tetrasodium pyrophosphate Proteolytic enzyme 0-1 Non-haz ingredients 0 - 0.1 Sodium carbonate 30 - 60 Fab concentrate Tetrasodium pyrophosphate 0-1 Sodium hydroxide 0 - 0.1 Non-haz ingredients 60 - 100 Finish Powerball 3 in Sodium tripolyphosphate 30 - 60 1 Sodium carbonate 10 - <30 Sodium percarbonate 10 - <30 Sodium silicate <10 Non-ionic surfactant <10 Proteolytic enzyme <1 Amylase enzyme <1 Non-haz ingredients to 100 Sodium tripolyphosphate 30 - 50 Sodium carbonate 15 - 30 Sodium carbonate peroxyhydrate 5 -15 Sodium disilicate Finish Powerball 5 in Fatty alcohol alkoxylate (1) <5 1 Fatty alcohol alkoxylate (2) <5 Proteolytic enzyme <1 Zinc sulphate <1 Amylase enzyme <0.25 <0.1 Sodium carbonate 10 - 100 Sodium percarbonate 1 -10 Home Brand 3 in 1 Sodium silicate 1 -10 Alcohols C12 - C15 ethoxylated 1 -10 propoxylated Morning Fresh 5 in 1 No information as yet Sodium carbonate 30 - 60 Sodium percarbonate 10 - <30 Napisan Plus Sodium silicate <10 Anionic surfactant <10 Proteolytic enzymes <10 Non-haz ingredients to 100 Alkali salts 10 -30 Omo matic Enzymes 0-10 Non-haz ingredients to 100 Radiant Micro No information concentrate Radiant Power No information concentrate Woolworths No information confirmed as dishwasher tablets 5 yet, however, same MSDS
in 1 supplied as for Homebrand Woolworths laundry No information confirmed as powder Advanced yet, however, same MSDS
supplied as for Homebrand Woolworths laundry No information confirmed as powder Front Loader yet, however, same MSDS
supplied as for Homebrand Spree concentrate Sodium sulphate Apple Fresh Sodium carbonate Pentasodium triphosphate Sodium silicate Tetrasodium pyrophosphate Sodium hydroxide Non-haz ingredients S week 4 in 1 No information as yet Surf Tropical Alkali salts 10 - 30 Non-haz ingredients to 100 Table 1 demonstrates that commercially available washing detergents possess a TNT
converting ability. The nature of this conversion may involve, amongst other reactions, chemical reduction of one, or more, of the nitrate groups on the TNT molecule to amines, a well established reaction observed in nature. One result of this conversion of TNT is a loss of part, or all, of the Pentolites explosive potential and a rendering of the device less prone to initiation.
This conversion of TNT may also enhance the biodegradation of the device, due to removal of TNT, a chemical known in the art, to be toxic to living organisms, including soil borne microbes.
This conversion of TNT as demonstrated in Table 1, whilst occurring in the presence of strong base, as shown with the sodium hydroxide control value, is enhanced by the presence of enzymes in the commercial detergent preparations. It is accepted that enzymes accelerate chemical reactions including various conversions of PETN and TNT.
It is also known that enzymes possess the potential to interact with chemicals other than their intended, or preferred substrate. One example of this is the action of PETN
reductase on TNT, two functionally related, but structurally unrelated compounds.
Thus the ability of non-TNT or PETN specific enzymes contained in detergent formulations including, but not limited to, proteases, amylases, lacasses and other unspecified enzymes, to convert TNT can be explained.
Example 2 Enzymatic degradation of Oxalate It is established that oxalate is the major alkaline degradation product of TNT. It is thus thermodynamically favourable to remove this end product in order to increase the efficiency of alkaline degradation of TNT, or other aromatics.
Thirty commercially available enzymes were selected for screening to determine their level of oxalate degradation. Apart from commercial availability, other criteria relevant to selection of enzymes for consideration were cost per application and lack of co-factor requirement. Oxalate degrading enzymes previously reported in the scientific literature did not meet these criteria.
Two enzymes, Papain (Enzyme Solutions, Australia) and Bromelain (Enzyme Solutions, Australia) reproducibly demonstrated oxalate-degrading activity (see the following table).
Degradation of oxalate by commercially feasible enzymes Enzyme Oxalate (mM) Degradation Papain 0.030 97%
Bromelain 0.732 27%
Control 0.997 0%
Experimental One ml reactions were performed to demonstrate oxalate degradation in 10 mM
potassium phosphate (pH 7.4) buffer containing 1 mM sodium oxalate (Sigma Aldrich, Australia) in water. Reactions commenced with the addition of 10 mg enzyme and were incubated at room temperature on a rotating mixer for 16 hours. In parallel, 1 mM sodium oxalate was incubated in the absence of enzyme as a control. Following incubation, reactions were heated to 85 C for 30 min. Samples were taken for oxalate concentration determination after sample centrifugation at 16100 x g for 5 min.
Oxalate determinations were performed immediately using an Oxalate detection kit (Trinity, Ireland). During the reaction, oxalate was oxidised to carbon dioxide and hydrogen peroxide by oxalate oxidase. The hydrogen peroxide was measured by its reaction with 3-methyl-2-benzothiazolinone hydrazone (MBTH) and 3-(dimethylamino) benzoic acid (DMAB) in the presence of peroxidase to yield an indamine dye, which has an absorbance maximum at 590 nm. The intensity of the color produced is directly proportional to the concentration of oxalate in the sample.
To determine oxalate concentration, 10 L of sample was mixed with 200 gL of oxalate reagent A and then with 20 gL oxalate reagent B. Samples were measured in duplicate. 10 mM potassium phosphate buffer was used as a blank control. Standard curves was generated using 0.1, 0.2, 0.5, 1 and 2 mM sodium oxalate (Sigma Aldrich, Australia). After incubation for 5 min at room temperature, absorbance was measured at 595 nm using a FLUOstar OPTIMA 96 well spectrophotometer (BMG Labtech, Australia).
Example 3 Enzymatic degradation of RDX
The cyanuric acid hydrolase enzyme (AtzD) participates in the degradation and mineralisation of atrazine, a triazine compound commonly found in the environment due its large-scale use as a herbicide. The pathway of atrazine degradation is encoded by a series of enzymes notated as AtzA, AtzB, AtzC, AtzD, AtzE, AtzF in order of sequential action on atrazine metabolites. (Martinez, B., J. Tomkins, L. P. Wackett, R.
Wing, and M.
J. Sadowsky. 2001. Complete nucleotide sequence and organization of the atrazine catabolic plasmid pADP-1 from Pseudomonas sp. strain ADP. J. Bacteriol.
183:5684-5697). Of note is that the enzymes following AtzD serve to degrade Cyanuric acid to carbon dioxide nand ammonia, thus AtzD is a triazine ring breaking enzyme.
The following schematic demonstrates the rationale for use of AtzD in RDX
degradation due to the similarities in their chemical structures.
In Figure 2 the shell 12 includes radial members 14 extending into the bulk of the explosive composition. The intention here is that when the cartridge 1 comes into contact with water, water dissolves the shell (12) so that water is conveyed into contact with and through the explosive composition, as required by certain embodiments of the invention described herein. The rate at which the shell (12) dissolves may be controlled by suitable selection of material used to form the shell (12).
The material making up the shell (12), passages 13 and/or radial members 14 may be formed of a material that may be degraded by the action of microorganisms. As the shell (12) is degraded this allows water present in the environment to contact the deactivating agent provided in the explosive composition (11) or shell (12). In turn this renders the deactivating agent suitably mobile and/or active so that the deactivating agent can commence desensitisation of the explosive composition. The microorganisms may also have the effect of acting on the explosive composition to convert it into less detonable or non-detonable by-products and/or by-products that are more environmentally friendly.
Figure 6 shows and explosive cartridge (1) suitable for use in seismic exploration. The cartridge (1) includes an explosive composition (a) and deactivating agent (b) in respective chambers (2,3). The chamber for the explosive composition (a) is in the form of a cylindrical shell comprising wall portions (2') sealed by a base (2"). The explosive composition (a) may be Pentolite, possibly in mixture with RDX and/or aluminium particles. The deactivating agent (b) may be a dishwasher detergent containing enzymes and alkaline salts that are capable of deactivating the explosive composition.
The explosive composition (a) and deactivating agent (b) are separated in their respective chambers by a base plate (14) that is loosely fitted at the lower end of the chamber (3) for the deactivating agent (b). The plate (14) may be formed of any suitable material such as a polyester or polycarbonate. The plate (14) may be provided with a double-sided adhesive to allow it to be positioned and retained in place - the purpose of the plate is to prevent contact between the deactivating agent (a) and explosive composition (b). That said, depending upon the nature of the deactivating agent and explosive composition it may be possible to dispense with the plate (14) altogether.
The cartridge (1) also includes two detonator receiving channels (5') extending into the explosive composition (a). The cartridge (1) also includes a cap (15) at one end. This cap (15) is sized and shaped to fit, for example by interference fit, into the shell housing the explosive composition.
In practice the cartridge (1) may be provided as separate components that are assembled during loading of respective components and when used in the field. With respect to Figure 6, one component may be integrally formed (by injection moulding of a plastics material) to include and define, the cap (15), the detonator receiving channels (5') and the chamber (3) for the deactivating agent (b) as illustrated in Figures 7 and 8.
The base plate (14) and chamber/shell (2) for the explosive composition (a) are separate components. The chamber (2) is made up of a cylindrical tube comprising wall portions (2') and a base (2") that is attached at a lower end of the tube thereby sealing it.
Figures 7 and 8 illustrate certain components shown in Figure 6. Thus, Figures 7 and 8 show the cap (15), detonating receiving channels (5') and chamber (3) for the deactivating agent formed as a one-piece construction, for example by injection moulding of a suitable plastics material. The chamber (3) for the deactivating agent is sealed by a separate plate (14). The cap (15) comprises a circular wall portion (15a) with a lip (15b) that enables the cap (15) to be secured (by interference fit) into a suitably sized and shaped chamber in which an explosive composition is provided (not shown in Figures 7 and 8). The cap (15) is typically inserted into a tube forming. The wall portions (2') extend above and below the cap (15) once inserted and are adapted to allow attachment of other cartridges or a nose cone, for example by thread fitting. The internal surface of the wall portion (2') may include a lug or tab to engage the lip (15b) so as to maintain the cap (15) in position. The upper end of the cap (15) is open to allow for insertion of at least one detonator into respective detonator receiving channels (5'). The end of the cap (15c) may be sealed with a suitably sized and shaped lid (not shown) or be formed in an injection moulding process.
The cap (15) and/or wall portions (2') may include apertures to allow water to enter the explosive cartridge. As noted the wall portion (2') extending above the position of the cap (15) may receive the lower end of another explosive cartridge to form a train of cartridges.
In this regard a surface (15c) of the wall portion (2') may be threaded to mate with corresponding threads provided on the outer surface and at the base of another cartridge.
Cartridges may also be coupled by interference fit or by clip fasteners. The cap (15) may include apertures or grooves (not shown) in the side wall thereof extending through the circular wall portion (15a) and lip (15b) through which detonator leads may be passed after a detonator loading.
The embodiment illustrated in Figures 6-8 may be implemented as follows. In the orientation shown in Figure 8 the plate (14) is removed and deactivating agent inserted into the chamber (3). The plate (14) is then replaced thereby sealing the chamber (3). The seal is loose in the sense that the chamber (3) is not liquid tight. Still in the orientation shown in Figure 8, a cylindrical tube defining the wall portions (2') of the chamber (2) for the explosive composition (a) is inserted over the cap (15) with the cap (15) being retained in place by interference fit between the wall portion (2') and cap lip (15b).
An explosive composition, such as Pentolite, can then be poured into the open end of the tube, thereby surrounding the chamber (3) and detonator receiving channels (5'). If Pentolite is used it is cast above its melting point and allowed to solidify.
Solidification may result in the formation of cracks and fissures extending through the bulk of the explosive composition. This may be desirable as such cracks and fissures allow water to travel through the explosive composition, as may be desired. Once the tube has been suitably filled with explosive composition, and the composition solidified as might be necessary, a base (2") is attached to the open end of the tube. The base (2") and wall portions (2') may form a seal by interference fit, male-female screw threading or by clip fastening.
In use the component so-formed is loaded with one or more detonators with the detonator leads being passed out of the cap (15) or upper part of wall portions (2') as noted. The top end of the cap (15) may itself be sealed using a lid made of water-degradable material (not shown).
In the embodiment described it is intended that the deactivating agent is rendered mobile by water entering the chamber (3) around the edges of the plate (14). The plate may additionally or alternatively include apertures to allow water entry into the chamber (3).
Additionally or alternatively, the wall portions of the chamber (3) may also include structures to allow water to enter the chamber (3) (the chamber (3) may itself be made of water-degradable material to facilitate water ingress). Water mobilises the deactivating agent and the mobilised deactivating agent may exit the chamber (3) for contact with explosive composition via the same (or different) route through which water entered the chamber (3).
Water may find its way into the chamber (3) in one or a combination of more than one way, as follows.
Where respective components are joined together, for example the wall portions (2') forming the chamber (2) and the cap (15) or the wall portions (2') and base (2"), the joint may allow water ingress. In this case water would enter the chamber (3) around the plate (14) by migration through the bulk of the explosive composition. The composition must therefore allow water transport by the presence of artificial and/or intrinsic water transport structures.
Additionally or alternatively, water may enter the explosive composition through the walls (2') and/or base (2") of the chamber (2). One or both of these components may include channels/apertures to allow water entry and/or one or both may be water-permeable or water-degradable. The exact configuration will depend upon the form of, and thus the containment needs, of the explosive composition.
Additionally or alternatively, water may enter the chamber (3) via the cap (15). Thus, the cap (15) may include channels/apertures extending through the cap (15) and into the chamber (3), for example through an aperture between the inner surface (15c) and the chamber (3). The aperture may itself be sealed by a water-degradable material.
Water may enter the cap (15) through loose fitting seals (between the cap (15) and cap lid or between the wall portion (2') and an adjacent cartridge when a train of multiple cartridges is assembled). The apertures/grooves for the detonator leads may also allow water to enter the cap. Apertures/grooves in the upper part of the wall portions (2') may also allow water ingress.
One or more components of the cartridge may be water-degradable, and the degradability may be selective in order to provide enhanced control with respect to intended deactivation of the explosive composition.
Irrespective of the way in which water enters the chamber (3), when the deactivating agent is mobilised it will exit the chamber (3) and contact the explosive composition, thereby commencing deactivation of the explosive composition.
Embodiments of the present invention are illustrated in the following non-limiting example.
Example 1 500 ml of water was heated to 45 C in a water bath. Pentolite was added to 200ppm (200mg/L), consisting of 70ppm PETN and 130ppm TNT. Deactivating agent (in the form of commercially available detergent) at the recommended dose rate and at 10 x the recommended dose rate was added as noted in Table 1 below. The resultant solution was then removed from the water bath and allowed to sit at room temperature (21 C) overnight in the dark. Samples were taken and analysed for PETN and TNT. The experiment was repeated using sodium hydroxide and water as controls. The results are presented in Table 1 below. Table 2 below provides a list of ingredients as declared in relevant Material Safety Data Sheets (MSDSs) for the detergents used in the experiments.
Table 1 Reagent Dose (g/L) PETN (mg/L) TNT (mg/
Biozet (standard dose) 0.417 45 83 Cold Power concentrate (standard dose) 1.67 43 54 Cold Power rainforest (standard dose) 1.67 41 66 Drive concentrate (standard dose) 1.75 49 62 Duo matic (standard dose) 3.5 50 24 Dynamo matic (standard dose) 3.6 43 43 Fab concentrate (standard dose) 1.5 43 53 Finish Powerball 3 in I (standard dose) 2.1 40 45 Finish Powerball 5 in 1 (standard dose) 2.1 34 56 Home Brand 3 in 1 (standard dose) 2.05 37 43 Morning Fresh 5 in 1 (standard dose) 1.82 43 75 Napisan Plus (standard dose) 4 48 0.2 Omo matic (standard dose) 3.17 38 35 Radiant Micro concentrate (standard dose) 0.7 38 88 Radiant Power concentrate (standard dose) 1.58 34 32 Woolworths dishwasher tablets 5 in 1 (standard dose) 2.14 37 37 Woolworths laundry powder Advanced (standard dose) 1.17 46 64 Woolworths laundry powder Front Loader (standard dose) 2.33 39 40 Spree concentrate Apple Fresh (standard dose) 1.67 45 35 Squeek 4 in 1 (standard dose) 1.1 43 14 Surf Tropical (standard dose) 1.5 48 64 Biozet (I Ox dose) 4.17 41 11 Cold Power concentrate (l Ox dose) 16.7 51 3.2 Cold Power rainforest (l Ox dose) 16.7 48 8.5 Drive concentrate (l Ox dose) 17.5 48 13 Duo matic (I Ox dose) 35 52 0.2 Dynamo matic (I Ox dose) 36 4.4 0.5 Fab concentrate (l Ox dose) 15 40 4.7 Finish Powerball 3 in I (lOx dose) 21 32 0.4 Finish Powerball 5 in I (lOx dose) 21 32 1.3 Home Brand 3 in I (l Ox dose) 20.5 24 <0.1 Morning Fresh 5 in 1 (l Ox dose) 18.2 29 5.7 Napisan Plus (l Ox dose) 40 51 <0.1 Omo matic (l Ox dose) 31.7 45 2.8 Radiant Micro concentrate (l Ox dose) 7 40 36 Radiant Power concentrate (l Ox dose) 15.8 39 0.5 Woolworths dishwasher tablets 5 in 1 (l Ox dose) 21.4 17 <0.1 Woolworths laundry powder Advanced (1 Ox dose) 11.7 42 25 Woolworths laundry powder Front Loader (l Ox dose) 23.3 28 21 Spree concentrate Apple Fresh (l Ox dose) 16.7 31 0.7 Squeek 4 in I (l Ox dose) 11 16 <0.1 Surf Tropical (1 Ox dose) 15 21 6.8 Control - 45 110 0.004 M NaOH control 0.167 40 1.0 Table 2 Detergent Ingredients (as per MSDS) Name Proportion Biozet No information as yet Pentasodium triphosphate 10 - 30 Sodium sulphate 10 - 30 Sodium carbonate 10 - 30 Cold Power Sodium tridecyl benzene 0-10 concentrate sulphonate (linear) Sodium silicate 0-5 Sodium silicoaluminate 0-5 Non-haz ingredients to 100 Sodium sulphate 30 - 60 Pentasodium triphosphate 10-30 Cold Power Sodium silicate 1-10 rainforest Tetrasodium pyrophosphate 0-1 Sodium hydroxide 0 - 0.1 Non-haz ingredients to 100 Alkaline salts 10-30 Drive concentrate Anionic surfactants 10-30 Enzymes 0-10 Non-haz ingredients to 100 Sodium tripolyphosphate Proportions not supplied Duo matic Sodium xylene sulphonate Dodecyl benzene sulphonate Sodium carbonate 10 - 30 Ethoxylated C 12 - C 15 alchohol 0-5 Dynamo matic Tetrasodium pyrophosphate Proteolytic enzyme 0-1 Non-haz ingredients 0 - 0.1 Sodium carbonate 30 - 60 Fab concentrate Tetrasodium pyrophosphate 0-1 Sodium hydroxide 0 - 0.1 Non-haz ingredients 60 - 100 Finish Powerball 3 in Sodium tripolyphosphate 30 - 60 1 Sodium carbonate 10 - <30 Sodium percarbonate 10 - <30 Sodium silicate <10 Non-ionic surfactant <10 Proteolytic enzyme <1 Amylase enzyme <1 Non-haz ingredients to 100 Sodium tripolyphosphate 30 - 50 Sodium carbonate 15 - 30 Sodium carbonate peroxyhydrate 5 -15 Sodium disilicate Finish Powerball 5 in Fatty alcohol alkoxylate (1) <5 1 Fatty alcohol alkoxylate (2) <5 Proteolytic enzyme <1 Zinc sulphate <1 Amylase enzyme <0.25 <0.1 Sodium carbonate 10 - 100 Sodium percarbonate 1 -10 Home Brand 3 in 1 Sodium silicate 1 -10 Alcohols C12 - C15 ethoxylated 1 -10 propoxylated Morning Fresh 5 in 1 No information as yet Sodium carbonate 30 - 60 Sodium percarbonate 10 - <30 Napisan Plus Sodium silicate <10 Anionic surfactant <10 Proteolytic enzymes <10 Non-haz ingredients to 100 Alkali salts 10 -30 Omo matic Enzymes 0-10 Non-haz ingredients to 100 Radiant Micro No information concentrate Radiant Power No information concentrate Woolworths No information confirmed as dishwasher tablets 5 yet, however, same MSDS
in 1 supplied as for Homebrand Woolworths laundry No information confirmed as powder Advanced yet, however, same MSDS
supplied as for Homebrand Woolworths laundry No information confirmed as powder Front Loader yet, however, same MSDS
supplied as for Homebrand Spree concentrate Sodium sulphate Apple Fresh Sodium carbonate Pentasodium triphosphate Sodium silicate Tetrasodium pyrophosphate Sodium hydroxide Non-haz ingredients S week 4 in 1 No information as yet Surf Tropical Alkali salts 10 - 30 Non-haz ingredients to 100 Table 1 demonstrates that commercially available washing detergents possess a TNT
converting ability. The nature of this conversion may involve, amongst other reactions, chemical reduction of one, or more, of the nitrate groups on the TNT molecule to amines, a well established reaction observed in nature. One result of this conversion of TNT is a loss of part, or all, of the Pentolites explosive potential and a rendering of the device less prone to initiation.
This conversion of TNT may also enhance the biodegradation of the device, due to removal of TNT, a chemical known in the art, to be toxic to living organisms, including soil borne microbes.
This conversion of TNT as demonstrated in Table 1, whilst occurring in the presence of strong base, as shown with the sodium hydroxide control value, is enhanced by the presence of enzymes in the commercial detergent preparations. It is accepted that enzymes accelerate chemical reactions including various conversions of PETN and TNT.
It is also known that enzymes possess the potential to interact with chemicals other than their intended, or preferred substrate. One example of this is the action of PETN
reductase on TNT, two functionally related, but structurally unrelated compounds.
Thus the ability of non-TNT or PETN specific enzymes contained in detergent formulations including, but not limited to, proteases, amylases, lacasses and other unspecified enzymes, to convert TNT can be explained.
Example 2 Enzymatic degradation of Oxalate It is established that oxalate is the major alkaline degradation product of TNT. It is thus thermodynamically favourable to remove this end product in order to increase the efficiency of alkaline degradation of TNT, or other aromatics.
Thirty commercially available enzymes were selected for screening to determine their level of oxalate degradation. Apart from commercial availability, other criteria relevant to selection of enzymes for consideration were cost per application and lack of co-factor requirement. Oxalate degrading enzymes previously reported in the scientific literature did not meet these criteria.
Two enzymes, Papain (Enzyme Solutions, Australia) and Bromelain (Enzyme Solutions, Australia) reproducibly demonstrated oxalate-degrading activity (see the following table).
Degradation of oxalate by commercially feasible enzymes Enzyme Oxalate (mM) Degradation Papain 0.030 97%
Bromelain 0.732 27%
Control 0.997 0%
Experimental One ml reactions were performed to demonstrate oxalate degradation in 10 mM
potassium phosphate (pH 7.4) buffer containing 1 mM sodium oxalate (Sigma Aldrich, Australia) in water. Reactions commenced with the addition of 10 mg enzyme and were incubated at room temperature on a rotating mixer for 16 hours. In parallel, 1 mM sodium oxalate was incubated in the absence of enzyme as a control. Following incubation, reactions were heated to 85 C for 30 min. Samples were taken for oxalate concentration determination after sample centrifugation at 16100 x g for 5 min.
Oxalate determinations were performed immediately using an Oxalate detection kit (Trinity, Ireland). During the reaction, oxalate was oxidised to carbon dioxide and hydrogen peroxide by oxalate oxidase. The hydrogen peroxide was measured by its reaction with 3-methyl-2-benzothiazolinone hydrazone (MBTH) and 3-(dimethylamino) benzoic acid (DMAB) in the presence of peroxidase to yield an indamine dye, which has an absorbance maximum at 590 nm. The intensity of the color produced is directly proportional to the concentration of oxalate in the sample.
To determine oxalate concentration, 10 L of sample was mixed with 200 gL of oxalate reagent A and then with 20 gL oxalate reagent B. Samples were measured in duplicate. 10 mM potassium phosphate buffer was used as a blank control. Standard curves was generated using 0.1, 0.2, 0.5, 1 and 2 mM sodium oxalate (Sigma Aldrich, Australia). After incubation for 5 min at room temperature, absorbance was measured at 595 nm using a FLUOstar OPTIMA 96 well spectrophotometer (BMG Labtech, Australia).
Example 3 Enzymatic degradation of RDX
The cyanuric acid hydrolase enzyme (AtzD) participates in the degradation and mineralisation of atrazine, a triazine compound commonly found in the environment due its large-scale use as a herbicide. The pathway of atrazine degradation is encoded by a series of enzymes notated as AtzA, AtzB, AtzC, AtzD, AtzE, AtzF in order of sequential action on atrazine metabolites. (Martinez, B., J. Tomkins, L. P. Wackett, R.
Wing, and M.
J. Sadowsky. 2001. Complete nucleotide sequence and organization of the atrazine catabolic plasmid pADP-1 from Pseudomonas sp. strain ADP. J. Bacteriol.
183:5684-5697). Of note is that the enzymes following AtzD serve to degrade Cyanuric acid to carbon dioxide nand ammonia, thus AtzD is a triazine ring breaking enzyme.
The following schematic demonstrates the rationale for use of AtzD in RDX
degradation due to the similarities in their chemical structures.
, 11+
N
_ N J`N
O N N' NO-II / .
N HONOH
_O. O
RDX Cyanuric acid Experimental The DNA encoding AtzD was cloned into the plasmid vector pET-14b (Novagen, Australia) and produced by over-expression in E. coli with IPTG induction by standard methods (Sambrook J & Russell D. 2000. Molecular Cloning: A Laboratory Manual [Third Edition]). The AtzD from Pseudomonas sp. strain ADP (GENBANK accession no.
AAK50331) was used in the present example, however, as it is isofunctional with TrzD
(GENBANK accession no. AAC61577) and selected sequence homolgues these can be interchanged.
RDX stock solutions were prepared in acetone at 40 mg/ml. Enzyme reactions were performed in Reconstituted Natural Water (RNW), which contains 1 mM KHCO3, 0.5 mM
CaC12, 0.206 mM MgSO4, 8.95 M FeSO4, and 0.25 mM HCl in MilliQ water in order to mimic environmental conditions.
RDX was added to a final concentration of 20 ppm into 5 ml RNW. Reactions were started with the addition of 100 ppm AtzD enzyme lysate freeze-dried powder (38.1 IU/g).
Samples were incubated at room temperature for 48 h and then stopped by the addition of 5mL acetonitrile. Analysis was then performed by HPLC.
N
_ N J`N
O N N' NO-II / .
N HONOH
_O. O
RDX Cyanuric acid Experimental The DNA encoding AtzD was cloned into the plasmid vector pET-14b (Novagen, Australia) and produced by over-expression in E. coli with IPTG induction by standard methods (Sambrook J & Russell D. 2000. Molecular Cloning: A Laboratory Manual [Third Edition]). The AtzD from Pseudomonas sp. strain ADP (GENBANK accession no.
AAK50331) was used in the present example, however, as it is isofunctional with TrzD
(GENBANK accession no. AAC61577) and selected sequence homolgues these can be interchanged.
RDX stock solutions were prepared in acetone at 40 mg/ml. Enzyme reactions were performed in Reconstituted Natural Water (RNW), which contains 1 mM KHCO3, 0.5 mM
CaC12, 0.206 mM MgSO4, 8.95 M FeSO4, and 0.25 mM HCl in MilliQ water in order to mimic environmental conditions.
RDX was added to a final concentration of 20 ppm into 5 ml RNW. Reactions were started with the addition of 100 ppm AtzD enzyme lysate freeze-dried powder (38.1 IU/g).
Samples were incubated at room temperature for 48 h and then stopped by the addition of 5mL acetonitrile. Analysis was then performed by HPLC.
Degradation of RDX by AtzD
Sample RDX (ppm) RDX degradation 100ppm AtzD 4.6 51.6%
Control 9.5 0%
Example 4 Degradation of PETN with Nitrate Ester Reductase Purification and Identification of nitrate ester reductase A bacterial strain, identified by 16S rDNA sequencing as belonging to the species Agrobacterium tumefaciens and denoted PD31 (PETN Degrading) was isolated from using methods known in the art. The 16S rDNA sequence was amplified using the DNA
primer pair 616V (5'- AGAGTTTGATYMTGGCTC) and 1492R (5'-GGYTACCTTGTTACGACTT). The complete DNA sequence encompassed by these primers is shown below. This DNA sequence was used to interrogate the DNA
sequence databases and found to be identical to that of Agrobacterium tumefaciens 16S
rDNA
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) This microbe was isolated via its ability to grow in a culture medium limited to PETN as the only nitrogen source.
PD31 16s rDNA sequence 1 gagggggggg gcttaccatg cagtcgaacg ccccgcaagg ggagtggcag 51 acgggtgagt aacgcgtggg aacataccct ttcctgcgga atagctccgg 101 gaaactggaa ttaataccgc atacgcccta cgggggaaag atttatcggg 151 gaaggattgg cccgcgttgg attagctagt tggtggggta aaggcctacc 201 aaggcgacga tccatagctg gtctgagagg atgatcagcc acattgggac 251 tgagacacgg cccaaactcc tacgggaggc agcagtgggg aatattggac 301 aatgggcgca agcctgatcc agccatgccg cgtgagtgat gaaggcctta 351 gggttgtaaa gctctttcac cggagaagat aatgacggta tccggagaag 401 aagccccggc taacttcgtg ccagcagccg cggtaatacg aagggggcta 451 gcgttgttcg gaattactgg gcgtaaagcg cacgtaggcg gatatttaag 501 tcaggggtga aatcccagag ctcaactctg gaactgcctt tgatactggg 551 tatcttgagt atggaagagg taagtggaat tccgagtgta gaggtgaaat 601 tcgtagatat tcggaggaac accagtggcg aaggcggctt actggtccat 651 tactgacgct gaggtgcgaa agcgtgggga gcaaacagga ttagataccc 701 tggtagtcca cgccgtaaac gatgaatgtt agccgtcggg cagtatactg 751 ttcggtggcg cagctaacgc attaaacatt ccgcctgggg agtacggtcg 801 caagattaaa actcaaagga attgacgggg gcccgcacaa gcggtggagc 851 atgtggttta attcgaagca acgcgcagaa ccttaccagc tcttgacatt 901 cggggtatgg gcattggaga cgatgtcctt cagttaggct ggccccagaa 951 caggtgctgc atggctgtcg tcagctcgtg tcgtgagatg ttgggttaag 1001 tcccgcaacg agcgcaaccc tcgcccttag ttgccagcat ttagttgggc 1051 actctaaggg gactgccggt gataagccga gaggaaggtg gggatgacgt 1101 caagtcctca tggcccttac gggctgggct acacacgtgc tacaatggtg 1151 gtgacagtgg gcagcgagac agcgatgtcg agctaatctc caaaagccat 1201 ctcagttcgg attgcactct gcaactcgag tgcatgaagt tggaatcgct 1251 agtaatcgca gatcagcatg ctgcggtgaa tacgttcccg ggccttgtac 1301 aacaccgccc gtcacaccat ggggagttgg ttttacccgg aaggtaagtg 1351 cgctaaaccg caaggaggca gctaaccacg tagtccgtt Agrobacterium tumefaciens PD31 16SrDNA sequence amplified by 616V/1492R primer pair This microbe (PD3 1) was not observed to have any specific growth requirements and was routinely cultured in non-defined media, such as PCA (0.5% peptone, 0.25%
yeast extract, 0.1% glucose, with addition of 2% agar as required). Growth of this microbe was observed at all temperatures tested (20-37 C). The PETN degrading capacity of PD31 was not inducible, in contrast to other nitrate ester degrading strains. PD31 Nitrate Ester Reductase (NER) activity was nicotinamide co-factor dependent, however, in contrast to many bacterial NERs, PD31 preferred NADH to NADPH (Table 1).
Enzymatic NER activity was determined by monitoring nitrite production in 50 mM
potassium phosphate buffer (pH 7.2), containing 0.2 mM PETN, and 0.2 mM NADH
in a final volume of 0.9 ml; 100 gl of enzyme solution was added to begin the reaction. Assays were incubated at room temperature for 5 minutes and then stopped by addition of phenazine methosulfate (0.2 mM, final concentration) and ferricyanide (0.5 mM, final concentration). Nitrite concentration was determined using the Aquanal-plus nitrite kit (Sigma, Cat. No. 37410) as per manufacturers instructions. One unit of activity was defined as the amount of enzyme required to release 1 mol of nitrite per min from PETN
under standard assay conditions.
Sample RDX (ppm) RDX degradation 100ppm AtzD 4.6 51.6%
Control 9.5 0%
Example 4 Degradation of PETN with Nitrate Ester Reductase Purification and Identification of nitrate ester reductase A bacterial strain, identified by 16S rDNA sequencing as belonging to the species Agrobacterium tumefaciens and denoted PD31 (PETN Degrading) was isolated from using methods known in the art. The 16S rDNA sequence was amplified using the DNA
primer pair 616V (5'- AGAGTTTGATYMTGGCTC) and 1492R (5'-GGYTACCTTGTTACGACTT). The complete DNA sequence encompassed by these primers is shown below. This DNA sequence was used to interrogate the DNA
sequence databases and found to be identical to that of Agrobacterium tumefaciens 16S
rDNA
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) This microbe was isolated via its ability to grow in a culture medium limited to PETN as the only nitrogen source.
PD31 16s rDNA sequence 1 gagggggggg gcttaccatg cagtcgaacg ccccgcaagg ggagtggcag 51 acgggtgagt aacgcgtggg aacataccct ttcctgcgga atagctccgg 101 gaaactggaa ttaataccgc atacgcccta cgggggaaag atttatcggg 151 gaaggattgg cccgcgttgg attagctagt tggtggggta aaggcctacc 201 aaggcgacga tccatagctg gtctgagagg atgatcagcc acattgggac 251 tgagacacgg cccaaactcc tacgggaggc agcagtgggg aatattggac 301 aatgggcgca agcctgatcc agccatgccg cgtgagtgat gaaggcctta 351 gggttgtaaa gctctttcac cggagaagat aatgacggta tccggagaag 401 aagccccggc taacttcgtg ccagcagccg cggtaatacg aagggggcta 451 gcgttgttcg gaattactgg gcgtaaagcg cacgtaggcg gatatttaag 501 tcaggggtga aatcccagag ctcaactctg gaactgcctt tgatactggg 551 tatcttgagt atggaagagg taagtggaat tccgagtgta gaggtgaaat 601 tcgtagatat tcggaggaac accagtggcg aaggcggctt actggtccat 651 tactgacgct gaggtgcgaa agcgtgggga gcaaacagga ttagataccc 701 tggtagtcca cgccgtaaac gatgaatgtt agccgtcggg cagtatactg 751 ttcggtggcg cagctaacgc attaaacatt ccgcctgggg agtacggtcg 801 caagattaaa actcaaagga attgacgggg gcccgcacaa gcggtggagc 851 atgtggttta attcgaagca acgcgcagaa ccttaccagc tcttgacatt 901 cggggtatgg gcattggaga cgatgtcctt cagttaggct ggccccagaa 951 caggtgctgc atggctgtcg tcagctcgtg tcgtgagatg ttgggttaag 1001 tcccgcaacg agcgcaaccc tcgcccttag ttgccagcat ttagttgggc 1051 actctaaggg gactgccggt gataagccga gaggaaggtg gggatgacgt 1101 caagtcctca tggcccttac gggctgggct acacacgtgc tacaatggtg 1151 gtgacagtgg gcagcgagac agcgatgtcg agctaatctc caaaagccat 1201 ctcagttcgg attgcactct gcaactcgag tgcatgaagt tggaatcgct 1251 agtaatcgca gatcagcatg ctgcggtgaa tacgttcccg ggccttgtac 1301 aacaccgccc gtcacaccat ggggagttgg ttttacccgg aaggtaagtg 1351 cgctaaaccg caaggaggca gctaaccacg tagtccgtt Agrobacterium tumefaciens PD31 16SrDNA sequence amplified by 616V/1492R primer pair This microbe (PD3 1) was not observed to have any specific growth requirements and was routinely cultured in non-defined media, such as PCA (0.5% peptone, 0.25%
yeast extract, 0.1% glucose, with addition of 2% agar as required). Growth of this microbe was observed at all temperatures tested (20-37 C). The PETN degrading capacity of PD31 was not inducible, in contrast to other nitrate ester degrading strains. PD31 Nitrate Ester Reductase (NER) activity was nicotinamide co-factor dependent, however, in contrast to many bacterial NERs, PD31 preferred NADH to NADPH (Table 1).
Enzymatic NER activity was determined by monitoring nitrite production in 50 mM
potassium phosphate buffer (pH 7.2), containing 0.2 mM PETN, and 0.2 mM NADH
in a final volume of 0.9 ml; 100 gl of enzyme solution was added to begin the reaction. Assays were incubated at room temperature for 5 minutes and then stopped by addition of phenazine methosulfate (0.2 mM, final concentration) and ferricyanide (0.5 mM, final concentration). Nitrite concentration was determined using the Aquanal-plus nitrite kit (Sigma, Cat. No. 37410) as per manufacturers instructions. One unit of activity was defined as the amount of enzyme required to release 1 mol of nitrite per min from PETN
under standard assay conditions.
GTN/PETN degrading activity of cell extract GTN (1U/mg protein) PETN (1U/mg protein) Sample No NADH NADPH No NADH NADPH
Cofactor Cofactor Agrobacterium tumefaciens 1.65x10-3 4.15x10-2 1.80x10-3 2.56x10' 1.59x10-2 8.58x10 PD31 cells grown for 40 hours in 2xYT medium (tryptone 16 g/L, yeast extract 1Og/L, NaCl 5g/L, glucose 2g/L) to an optical density at 600 rim of 5.44 were harvested by centrifugation (5000xg, 20 minutes) and resuspended in 125 mM Sodium Phosphate (pH
7.2) buffer containing the protease inhibitor mix (Complete - Roche, Australia). Samples were disrupted at 700 bar for 2.5 min using an Emulsiflex-C50 High Pressure Homogenizer (Avestin, Inc. Ottawa, Canada). The lysate sample was then clarified by centrifugation (10,000xg, 30 min) and passed through a 0.2micron filter.
Saturated ammonium sulphate solution was added to the supernatant to a final level of 40%
saturation. The sample was then incubated at 4 C for 1.5 hours, followed by centrifugation at 10,000 x g for 10 min at 4 C to sediment non-NER proteins. The ammonium sulphate concentration was then adjusted to 60% saturation with further addition of saturated solution and incubated for a further 1 hour at 4 C. This sample was then further centrifuged (10,000xg, 30 minutes) and the pellet resuspended into 50 mM
Sodium Phosphate (pH 7.0). At this stage the sample contained >50% PD31 NER protein and may be used in the degradation of PETN once appropriately stabilised.
All NER activity appeared to localise to a single protein.
To determine the identity of the NER protein in order to isolate its gene for use in recombinant production of this enzyme, the lysate sample was further fractionated by column chromatography. The sample was applied to a column packed with Sephadex G-100SF size exclusion resin (Amersham Pharmacia, Sweden) by techniques known in the art. The applied proteins were eluted with 50 mM Sodium Phosphate (pH 7.0) buffer in order maximise stability of the NER. Protein fractions were collected from the column and analysed for NER activity. One fraction, with the majority of the NER activity was further resolved by 12% SDS-PAGE, using standard techniques in the art, and found to contain a protein of approx. 40 kDa. This protein was excised from the SDS-PAGE gel and it's N-terminal sequence elucidated by standard techniques (Australian Proteome Analysis Facility, Macquarie University, Australia). The N-terminal sequence determined from this sample was: XX LFEPAQAG. This sequence was found to be homologous with two genes of similar reported function, the Glycerol TriNitrate reductase of Agrobacterium radiobacter (EMBL accession: Y13942) and an oxidoreductase of Agrobacterium tumefaciens C58 (GENBANK: NP_355149).
Example 5 Degradation of PETN with Nitrate Ester Reductase Identification, characterisation and expression of Agrobacterium tumefaciens nitrate ester reductase The N-terminal protein sequence of the Agrobacterium tumefaciens PD31 NER
enzyme (XXLFEPAQAG) was analysed in conjunction to the DNA encoding two homologous proteins (Glycerol TriNitrate reductase of Agrobacterium tumefaciens [EMBL
accession:
Y13942.1] and an oxidoreductase of Agrobacterium tumefaciens C58 [GENBANK:
NP_355149]) to design nucleotide primers for the amplification of the encoding gene.
These primers are shown below.
Nucleotide primers for amplification of the complete PD31 NER gene Primer Sequence (5'-3')* Homology GRDFNC GCACCATGGCCAGTCTTTTCGAACC 5' of ner GRDFND GCACATATGACCAGTCTTTTCGAACC 5' of ner GRDRBA ATCGGATCCCTATTGGGCGAGGGCCGGATAGTC 3' of ner GRD2RBA ACTGGATCCTCAGCCGAGTGCCGGATAGTC 3' of ner GRDR3 GGTCGCTGCTTTCGCTGCAC 3' flanking region GRDF CCAATCTCTGAGCCTCCCAAG 5' flanking region DNA restriction enzyme sites are shown underlined and are not homologous to the PD31 sequence, but are included to facilitate cloning of the gene The nucleotide primers shown above were used to amplify (by polymerase chain reaction) relevant sections of Agrobacterium tumefaciens PD31 DNA molecule. Methods known in the art were also used to purify and sequence this amplified DNA, the commensurate DNA
sequence is shown below.
1 atgacaagtc ttttcgaacc ggcacaggcc ggcgatatcg cactcgccaa 51 ccgtatcgtc atggctcccc tcacccgcaa ccggtcgccg ggagcaattc 101 ccaacaacct caacgccacc tattacgagc agcgtgcaac ggccgggctg 151 atcgttacgg aaggcacgcc gatttcccag cagggtcagg gctatgcgga 201 tgttccgggc ctctacaagc aggaagcggt cgaaggctgg aaaaagatca 251 ccgacggcgt gcattcggca ggcggcaaga ttgtcgcgca gatctggcac 301 gtagggcgca tttcccacac gtcgctccag ccgcatggcg gccagcctgt 351 cgccccttcg gccatccccg ccaaatcgaa gacctatatc atcaatgatg 401 acggcaccgg cgcctttgcg gaaacctccg agccgcgtgc actgaccatc 451 gacgatatcg gccttatcct cgaggactac cgcaccggcg cgcgcgcagc 501 acttgaggcc ggttttgacg gcgtcgaaat ccatgccgcc aacggttatc 551 tgatcgagca gttcctgaaa tccagcacca accagcgcac cgatgagtat 601 ggcggttcga tcgaaaaccg cgcccgcttc ctgctggaag tcgtggatgc 651 ggttgcggaa gagatcggcg cgggccgcac cggcatccgc ctttcccccg 701 tcacgccggc caacgatatt ttcgaggccg acccgcagcc gctttataac 751 tatgttgcgg aagaactcgg caagcggggc ctcgccttca tccatgtcgt 801 tgaaggtgca accggtggtc cacgcgactt caagcaaggc gacaaaccct 851 tcgattacgc cgccttcaag ggtgcctatc gcaatgccgg cggcaagggc 901 ctctggatcg ccaacaacgg ctacgaccgc cagagcgcca tcgaggcggt 951 ggaaagcggc agggtggatg ctgtggcctt cggcaaggcc tttattgcca 1001 atccggatct ggtgcgccgc ctgaaggacg acgcgccgct gaacgagccc 1051 aatcagccga ccttctatgg tggcggggct gaaggctata ccgactatcc 1101 ggctcttggc tga Coding DNA sequence of the Agrobacterium tumefaciens PD31 enzyme. Flanking regions are omitted.
This DNA sequence once translated yields the protein sequence shown below.
Cofactor Cofactor Agrobacterium tumefaciens 1.65x10-3 4.15x10-2 1.80x10-3 2.56x10' 1.59x10-2 8.58x10 PD31 cells grown for 40 hours in 2xYT medium (tryptone 16 g/L, yeast extract 1Og/L, NaCl 5g/L, glucose 2g/L) to an optical density at 600 rim of 5.44 were harvested by centrifugation (5000xg, 20 minutes) and resuspended in 125 mM Sodium Phosphate (pH
7.2) buffer containing the protease inhibitor mix (Complete - Roche, Australia). Samples were disrupted at 700 bar for 2.5 min using an Emulsiflex-C50 High Pressure Homogenizer (Avestin, Inc. Ottawa, Canada). The lysate sample was then clarified by centrifugation (10,000xg, 30 min) and passed through a 0.2micron filter.
Saturated ammonium sulphate solution was added to the supernatant to a final level of 40%
saturation. The sample was then incubated at 4 C for 1.5 hours, followed by centrifugation at 10,000 x g for 10 min at 4 C to sediment non-NER proteins. The ammonium sulphate concentration was then adjusted to 60% saturation with further addition of saturated solution and incubated for a further 1 hour at 4 C. This sample was then further centrifuged (10,000xg, 30 minutes) and the pellet resuspended into 50 mM
Sodium Phosphate (pH 7.0). At this stage the sample contained >50% PD31 NER protein and may be used in the degradation of PETN once appropriately stabilised.
All NER activity appeared to localise to a single protein.
To determine the identity of the NER protein in order to isolate its gene for use in recombinant production of this enzyme, the lysate sample was further fractionated by column chromatography. The sample was applied to a column packed with Sephadex G-100SF size exclusion resin (Amersham Pharmacia, Sweden) by techniques known in the art. The applied proteins were eluted with 50 mM Sodium Phosphate (pH 7.0) buffer in order maximise stability of the NER. Protein fractions were collected from the column and analysed for NER activity. One fraction, with the majority of the NER activity was further resolved by 12% SDS-PAGE, using standard techniques in the art, and found to contain a protein of approx. 40 kDa. This protein was excised from the SDS-PAGE gel and it's N-terminal sequence elucidated by standard techniques (Australian Proteome Analysis Facility, Macquarie University, Australia). The N-terminal sequence determined from this sample was: XX LFEPAQAG. This sequence was found to be homologous with two genes of similar reported function, the Glycerol TriNitrate reductase of Agrobacterium radiobacter (EMBL accession: Y13942) and an oxidoreductase of Agrobacterium tumefaciens C58 (GENBANK: NP_355149).
Example 5 Degradation of PETN with Nitrate Ester Reductase Identification, characterisation and expression of Agrobacterium tumefaciens nitrate ester reductase The N-terminal protein sequence of the Agrobacterium tumefaciens PD31 NER
enzyme (XXLFEPAQAG) was analysed in conjunction to the DNA encoding two homologous proteins (Glycerol TriNitrate reductase of Agrobacterium tumefaciens [EMBL
accession:
Y13942.1] and an oxidoreductase of Agrobacterium tumefaciens C58 [GENBANK:
NP_355149]) to design nucleotide primers for the amplification of the encoding gene.
These primers are shown below.
Nucleotide primers for amplification of the complete PD31 NER gene Primer Sequence (5'-3')* Homology GRDFNC GCACCATGGCCAGTCTTTTCGAACC 5' of ner GRDFND GCACATATGACCAGTCTTTTCGAACC 5' of ner GRDRBA ATCGGATCCCTATTGGGCGAGGGCCGGATAGTC 3' of ner GRD2RBA ACTGGATCCTCAGCCGAGTGCCGGATAGTC 3' of ner GRDR3 GGTCGCTGCTTTCGCTGCAC 3' flanking region GRDF CCAATCTCTGAGCCTCCCAAG 5' flanking region DNA restriction enzyme sites are shown underlined and are not homologous to the PD31 sequence, but are included to facilitate cloning of the gene The nucleotide primers shown above were used to amplify (by polymerase chain reaction) relevant sections of Agrobacterium tumefaciens PD31 DNA molecule. Methods known in the art were also used to purify and sequence this amplified DNA, the commensurate DNA
sequence is shown below.
1 atgacaagtc ttttcgaacc ggcacaggcc ggcgatatcg cactcgccaa 51 ccgtatcgtc atggctcccc tcacccgcaa ccggtcgccg ggagcaattc 101 ccaacaacct caacgccacc tattacgagc agcgtgcaac ggccgggctg 151 atcgttacgg aaggcacgcc gatttcccag cagggtcagg gctatgcgga 201 tgttccgggc ctctacaagc aggaagcggt cgaaggctgg aaaaagatca 251 ccgacggcgt gcattcggca ggcggcaaga ttgtcgcgca gatctggcac 301 gtagggcgca tttcccacac gtcgctccag ccgcatggcg gccagcctgt 351 cgccccttcg gccatccccg ccaaatcgaa gacctatatc atcaatgatg 401 acggcaccgg cgcctttgcg gaaacctccg agccgcgtgc actgaccatc 451 gacgatatcg gccttatcct cgaggactac cgcaccggcg cgcgcgcagc 501 acttgaggcc ggttttgacg gcgtcgaaat ccatgccgcc aacggttatc 551 tgatcgagca gttcctgaaa tccagcacca accagcgcac cgatgagtat 601 ggcggttcga tcgaaaaccg cgcccgcttc ctgctggaag tcgtggatgc 651 ggttgcggaa gagatcggcg cgggccgcac cggcatccgc ctttcccccg 701 tcacgccggc caacgatatt ttcgaggccg acccgcagcc gctttataac 751 tatgttgcgg aagaactcgg caagcggggc ctcgccttca tccatgtcgt 801 tgaaggtgca accggtggtc cacgcgactt caagcaaggc gacaaaccct 851 tcgattacgc cgccttcaag ggtgcctatc gcaatgccgg cggcaagggc 901 ctctggatcg ccaacaacgg ctacgaccgc cagagcgcca tcgaggcggt 951 ggaaagcggc agggtggatg ctgtggcctt cggcaaggcc tttattgcca 1001 atccggatct ggtgcgccgc ctgaaggacg acgcgccgct gaacgagccc 1051 aatcagccga ccttctatgg tggcggggct gaaggctata ccgactatcc 1101 ggctcttggc tga Coding DNA sequence of the Agrobacterium tumefaciens PD31 enzyme. Flanking regions are omitted.
This DNA sequence once translated yields the protein sequence shown below.
1 mtslfepaga gdialanriv mapltrnrsp gaipnnlnat yyegratagl 51 ivtegtpisq qgqgyadvpg lykqeavegw kkitdgvhsa ggkivaqiwh 101 vgrishtslq phggqpvaps aipaksktyi inddgtgafa etsepralti 151 ddigliledy rtgaraalea gfdgveihaa ngylieqflk sstnqrtdey 201 ggsienrarf llevvdavae eigagrtgir lspvtpandi feadpqplyn 251 yvaeelgkrg lafihvvega tggprdfkqg dkpfdyaafk gayrnaggkg 301 lwianngydr qsaieavesg rvdavafgka fianpdlvrr lkddaplnep 351 nqptfyggga egytdypalg Protein sequence translated from the ner sequence. The amino-acids homologous to the experimentally determined N-terminus are shown in bold and underline.
This sequence is unique in the protein sequence databases searched (Non-redundant at http://blast.ncbi.nlm.nih.gov) and as anticipated from the N-terminal sequence, shares homology with the GTN reductase of Agrobacterium tumefaciens and an oxidoreductase of Agrobacterium tumefaciens C58.
In order to demonstrate the functionality of PD31 NER, nucleotide primers shown above were used to amplify and clone ner into the protein expression plasmid pET-14b (Novagen, Australia) by methods known in the art. Four separate recombinant proteins were expressed, corresponding to different terminal sequences. Possible terminal sequence parameters were: presence or absence of a histidine `tag', or a polymorphism at the end of the enzyme inserted by the reverse primers shown in the table above. The NER
activity data is shown below and demonstrates the function of this protein.
NER activities of various forms of recombinant Agrobacterium tumefaciens PD31 NER enzyme 5' 3' Optimal Induction IPTG Activity (oligonucleotide) (mM) (IU/mg) Native GRDRBA 0.05 0.821 His Tag GRDRBA 0.05 0.550 Native GRD2RBA 0.05 1.38 His Tag GRD2RBA 0.025 0.952 Enzymatic NER activity was determined by monitoring nitrite production in 50 mM
potassium phosphate buffer (pH 7.2), containing 0.2 mM PETN, and 0.2 mM NADH
in a final volume of 0.9 ml; 100 l of enzyme solution was added to begin the reaction. Assays were incubated at room temperature for 5 minutes and then stopped by addition of phenazine methosulfate (0.2 mM, final concentration) and ferricyanide (0.5 mM, final concentration). Nitrite concentration was determined using the Aquanal-plus nitrite kit (Sigma, Cat. No. 37410) as per manufacturers instructions. One unit of activity was defined as the amount of enzyme required to release 1 gmol of nitrite per min from PETN
under standard assay conditions.
The data shown in above clearly demonstrate that the gene isolated does indeed encode a NER and further, can be improved by varying its sequence and induction conditions.
The enzyme with the highest level of activity (Native 3' and GRD2RBA 5') has been used in all further studies where NER is used.
The recombinant NER enzyme was found to be similar to the wild-type enzyme in terms of thermal inactivation and retained approximately 50% of its activity when incubated at 85 C in solution. This thermal stability was improved when freeze-dried NER
was used.
The pH stability of NER is of relevance to its application and was assessed using 50 mM
buffers at various pH values (Buffers used: Sodium acetate buffer for pH 4.5-5.5;
Potassium phosphate buffer for pH 6-7.6; Tris buffer for pH 8-9;
Triethanolamine buffer for pH 8.5; and Sodium carbonate buffer for pH 10-11).
As shown in below, the Agrobacterium tumefaciens PD31 NER enzyme has a very wide pH optimum which is a distinct advantage to the application of this in the degradation of Pentolite.
This sequence is unique in the protein sequence databases searched (Non-redundant at http://blast.ncbi.nlm.nih.gov) and as anticipated from the N-terminal sequence, shares homology with the GTN reductase of Agrobacterium tumefaciens and an oxidoreductase of Agrobacterium tumefaciens C58.
In order to demonstrate the functionality of PD31 NER, nucleotide primers shown above were used to amplify and clone ner into the protein expression plasmid pET-14b (Novagen, Australia) by methods known in the art. Four separate recombinant proteins were expressed, corresponding to different terminal sequences. Possible terminal sequence parameters were: presence or absence of a histidine `tag', or a polymorphism at the end of the enzyme inserted by the reverse primers shown in the table above. The NER
activity data is shown below and demonstrates the function of this protein.
NER activities of various forms of recombinant Agrobacterium tumefaciens PD31 NER enzyme 5' 3' Optimal Induction IPTG Activity (oligonucleotide) (mM) (IU/mg) Native GRDRBA 0.05 0.821 His Tag GRDRBA 0.05 0.550 Native GRD2RBA 0.05 1.38 His Tag GRD2RBA 0.025 0.952 Enzymatic NER activity was determined by monitoring nitrite production in 50 mM
potassium phosphate buffer (pH 7.2), containing 0.2 mM PETN, and 0.2 mM NADH
in a final volume of 0.9 ml; 100 l of enzyme solution was added to begin the reaction. Assays were incubated at room temperature for 5 minutes and then stopped by addition of phenazine methosulfate (0.2 mM, final concentration) and ferricyanide (0.5 mM, final concentration). Nitrite concentration was determined using the Aquanal-plus nitrite kit (Sigma, Cat. No. 37410) as per manufacturers instructions. One unit of activity was defined as the amount of enzyme required to release 1 gmol of nitrite per min from PETN
under standard assay conditions.
The data shown in above clearly demonstrate that the gene isolated does indeed encode a NER and further, can be improved by varying its sequence and induction conditions.
The enzyme with the highest level of activity (Native 3' and GRD2RBA 5') has been used in all further studies where NER is used.
The recombinant NER enzyme was found to be similar to the wild-type enzyme in terms of thermal inactivation and retained approximately 50% of its activity when incubated at 85 C in solution. This thermal stability was improved when freeze-dried NER
was used.
The pH stability of NER is of relevance to its application and was assessed using 50 mM
buffers at various pH values (Buffers used: Sodium acetate buffer for pH 4.5-5.5;
Potassium phosphate buffer for pH 6-7.6; Tris buffer for pH 8-9;
Triethanolamine buffer for pH 8.5; and Sodium carbonate buffer for pH 10-11).
As shown in below, the Agrobacterium tumefaciens PD31 NER enzyme has a very wide pH optimum which is a distinct advantage to the application of this in the degradation of Pentolite.
100%
90%
80%
70%
60%
ro 50%
ro 40%
30%
20%
10%
0%
4.5 5 5.5 6 6.5 7 7.6 8 8.5 9 10 11 pH
PETN degrading activity of recombinant A. tumefaciens PD31 nitrate ester reductase at different pH.
Example 6 Degradation of Pentolite with Nitrate Ester Reductase Recycling of NADH
The Agrobacterium tumefaciens PD31 NER, like all related enzymes, is a nicotinamide (NADH) cofactor-dependent oxidoreductase. It contains a flavin mononucleotide non-covalently bound to the mature enzyme and catalyses the reductive cleavage of the nitrate ester group to yield an alcohol and liberate nitrite.
Due to this reaction mechanism, one mole of NADH is required to cleave each accessible nitrate group. The high cost of NADH and other reported co-factors renders the application of these enzymes non-commercially viable in all but specialty applications.
In order to reduce the cost per application of this enzyme, recombinant production of NER
in E.coli was accomplished, however, viable co-factors could not be identified. An alternative to this was the re-cycling of the native NADH co-factor, or indeed use of the cheaper and more stable NAD+ that may be converted to NADH in situ.
90%
80%
70%
60%
ro 50%
ro 40%
30%
20%
10%
0%
4.5 5 5.5 6 6.5 7 7.6 8 8.5 9 10 11 pH
PETN degrading activity of recombinant A. tumefaciens PD31 nitrate ester reductase at different pH.
Example 6 Degradation of Pentolite with Nitrate Ester Reductase Recycling of NADH
The Agrobacterium tumefaciens PD31 NER, like all related enzymes, is a nicotinamide (NADH) cofactor-dependent oxidoreductase. It contains a flavin mononucleotide non-covalently bound to the mature enzyme and catalyses the reductive cleavage of the nitrate ester group to yield an alcohol and liberate nitrite.
Due to this reaction mechanism, one mole of NADH is required to cleave each accessible nitrate group. The high cost of NADH and other reported co-factors renders the application of these enzymes non-commercially viable in all but specialty applications.
In order to reduce the cost per application of this enzyme, recombinant production of NER
in E.coli was accomplished, however, viable co-factors could not be identified. An alternative to this was the re-cycling of the native NADH co-factor, or indeed use of the cheaper and more stable NAD+ that may be converted to NADH in situ.
A variety of enzymes able to reduce NAD+ are reported in the scientific literature, with a majority applicable in some form to the degradation of nitrate esters. An assessment was performed on a number of these enzymes and the Pseudomonas fluorescens D-galactose dehydrogenase (GDH) was considered the best candidate on the basis of its relatively innocuous substrate. D-galactose is compatible with most explosives and has the added benefit of providing an excellent carbon source for continued biodegradation by native soil bacteria.
Experimental NER was produced as per previously described in this document.
Pseudomonas fluorescens strain 283/2 was kindly provided by RMIT University (Australia). For the non-recombinant production of GDH, one colony from an overnight culture was inoculated in 10 ml minimalM9 medium with 5 g/I D-galactose and 1 g/I
ammonium sulphate. After 48 h incubation at 30 C, 200 rpm, 10 ml culture was harvested and pellet resuspended into 1.5 ml 50 mM Tris (pH 7.2) buffer with 100 mM
NaCl. The resulting cell suspension was sonicated as is known in the art and D-galactose dehydrogenase activity of the supernatant was determined.
D-galactose dehydrogenase activity was assayed by monitoring the formation of NADH at 340 nm in a 1-ml reaction mixture consisting of 50 mM Tris buffer (pH 8.0), 2 mM NAD, and 0.3% (w/v) D-galactose. One unit of activity was defined as the amount of enzyme required to convert 1.0 gmol D-galactose to D-galactonate per minute at pH 8.0 at room temperature.
In order to generate the efficient recycling of NADH the following procedure was employed. Reactions were set up with 0.2 mM PETN or 100 ppm Pentolite, 23 IU/L
NER, 26.2 IU/L GDH, 11.1 mM D-galactose and NAD+ at concentrations of 0.02 or 0.002 mM
in 50 mM Tris pH 8.0 buffer. Controls omitted the addition of NER. Reactions were incubated at room temperature for 16 h. The samples were then diluted with 3 parts acetonitrile and PETN/TNT were estimated by HPLC-UV analysis.
PETN and Pentolite degradation by purified PD31 recombinant NER using a co-factor recycling system Sample NAD+ PETN PETN TNT TNT
(mM) (mM) degradation (mM) degradation PETN control 0.02 0.192 0% N/A N/A
PETN 0.02 0.081 57.8% N/A N/A
PETN 0.002 0.090 53.1% N/A N/A
Pentolite control 0.02 0.119 0% 0.220 0%
Pentolite 0.02 0.005 95.8% 0.026 87.7%
Pentolite 0.002 0.037 68.9% 0.211 4.3%
The table clearly demonstrates an example of the use of commercially feasible quantities of co-factor to drive degradation of Pentolite. It is noteworthy that the reaction proceeds to the point that TNT, a non-ideal substrate for NER is degraded.
Example 7 Degradation of Pentolite by Xanthine Oxidase Xanthine oxidase (XO) and its alternate form xanthine dehydrogenase diverge in a number of ways including the formers preference for oxygen and the latters for NAD+
as co-factors. Xanthine oxidase (XO) catalyses the oxidation of xanthine to uric acid, thus liberating two electrons and converting molecular oxygen and water to hydrogen peroxide.
An alternative process can begin at hypoxanthine which is also converted to uric acid, in a two-step process generating twice the electrons and hydrogen peroxide per mole (see the schematic below).
Experimental NER was produced as per previously described in this document.
Pseudomonas fluorescens strain 283/2 was kindly provided by RMIT University (Australia). For the non-recombinant production of GDH, one colony from an overnight culture was inoculated in 10 ml minimalM9 medium with 5 g/I D-galactose and 1 g/I
ammonium sulphate. After 48 h incubation at 30 C, 200 rpm, 10 ml culture was harvested and pellet resuspended into 1.5 ml 50 mM Tris (pH 7.2) buffer with 100 mM
NaCl. The resulting cell suspension was sonicated as is known in the art and D-galactose dehydrogenase activity of the supernatant was determined.
D-galactose dehydrogenase activity was assayed by monitoring the formation of NADH at 340 nm in a 1-ml reaction mixture consisting of 50 mM Tris buffer (pH 8.0), 2 mM NAD, and 0.3% (w/v) D-galactose. One unit of activity was defined as the amount of enzyme required to convert 1.0 gmol D-galactose to D-galactonate per minute at pH 8.0 at room temperature.
In order to generate the efficient recycling of NADH the following procedure was employed. Reactions were set up with 0.2 mM PETN or 100 ppm Pentolite, 23 IU/L
NER, 26.2 IU/L GDH, 11.1 mM D-galactose and NAD+ at concentrations of 0.02 or 0.002 mM
in 50 mM Tris pH 8.0 buffer. Controls omitted the addition of NER. Reactions were incubated at room temperature for 16 h. The samples were then diluted with 3 parts acetonitrile and PETN/TNT were estimated by HPLC-UV analysis.
PETN and Pentolite degradation by purified PD31 recombinant NER using a co-factor recycling system Sample NAD+ PETN PETN TNT TNT
(mM) (mM) degradation (mM) degradation PETN control 0.02 0.192 0% N/A N/A
PETN 0.02 0.081 57.8% N/A N/A
PETN 0.002 0.090 53.1% N/A N/A
Pentolite control 0.02 0.119 0% 0.220 0%
Pentolite 0.02 0.005 95.8% 0.026 87.7%
Pentolite 0.002 0.037 68.9% 0.211 4.3%
The table clearly demonstrates an example of the use of commercially feasible quantities of co-factor to drive degradation of Pentolite. It is noteworthy that the reaction proceeds to the point that TNT, a non-ideal substrate for NER is degraded.
Example 7 Degradation of Pentolite by Xanthine Oxidase Xanthine oxidase (XO) and its alternate form xanthine dehydrogenase diverge in a number of ways including the formers preference for oxygen and the latters for NAD+
as co-factors. Xanthine oxidase (XO) catalyses the oxidation of xanthine to uric acid, thus liberating two electrons and converting molecular oxygen and water to hydrogen peroxide.
An alternative process can begin at hypoxanthine which is also converted to uric acid, in a two-step process generating twice the electrons and hydrogen peroxide per mole (see the schematic below).
Hypoxanthine Xanthine Uric acid HN 1\,-"N HN I N~ HN' i N~
`~N N N N ~~..N*'N
H H H H
H2O + 02 H202 + 2e H2O + H202 + 2e-Of particular interest in this example is XO's co-factor promiscuity, allowing it to utilise a diverse range of electron acceptors, including nitrates. This property has been harnessed in this example of Pentolite degradation.
This example is significant as it demonstrates an enhanced degradation of PETN
when presented as formulated Pentolite. The exact mechanism for this is unclear, however, is most likely to occur due to reaction of free nitrates, TNT, PETN, inorganic or organic constituents of the Pentolite formulation. The interaction of these with XO or its reaction products through reactive oxygen species, or other intermediates may initiate a cascade whereby breakdown products are in turn reactive. This process may be synergistic or truly catalytic under appropriate conditions.
This example further demonstrates that both Xanthine and Hypoxanthine oxidation can lead to efficient degradation of Pentolite. Whilst hypoxanthine can be postulated to supply twice the degrading capacity, it is quite soluble and may dissolve faster than the target compounds, in this case PETN and TNT, thus limiting its utility in high water flow situations. Xanthine, which is significantly less soluble, would thus provide a rate of release more analogous to PETN and thus prove more effective in target degradation.
The relative quantities of Xanthine and Hypoxanthine will thus need to be adapted on the basis of a number of factors, including target solubility and environmental conditions. This example demonstrates one of these possibilities.
Experimental Bovine milk xanthine oxidase (Cat. No. X4875) was used in the examples below and was obtained from Sigma-Aldrich (Australia). Degradation assays were performed in 50 mM
potassium phosphate buffer (pH 7.2) with either 0.1 mM PETN or 100 ppm Pentolite as target substrate. Assays were performed in a volume of 3 ml and incubated for overnight at room temperature in the dark. Samples were then prepared for analysis by HPLC-UV by addition of 9 ml acetonitrile.
The following table demonstrates the degradation of PETN when 10mM xanthine is used as the oxidase substrate.
Degradation of PETN by XO (Xanthine substrate) Sample XO activity PETN PETN
(IU/L) (mg/L) degradation Xanthine Oxidase 500 2.8 66.3%
Control 0 8.3 0.0%
The following table compares the degradation of PETN as sole electron acceptor to the degradation of PETN as formulated Pentolite. Hypoxanthine (10 mM) was used as the oxidase substrate.
Degradation of Pentolite and PETN by 500 U/L XO (Hypoxanthine substrate) Sample presentation (mg/L) degradation (mg/L) degradation Xanthine Oxidase Pentolite <0.1 >98.6% <0.1 >99.3%
Control Pentolite 6.9 0.0% 14 0.0%
Xanthine Oxidase PETN 4.4 39.7% ND ND
Control PETN 7.3 0.0% ND ND
`~N N N N ~~..N*'N
H H H H
H2O + 02 H202 + 2e H2O + H202 + 2e-Of particular interest in this example is XO's co-factor promiscuity, allowing it to utilise a diverse range of electron acceptors, including nitrates. This property has been harnessed in this example of Pentolite degradation.
This example is significant as it demonstrates an enhanced degradation of PETN
when presented as formulated Pentolite. The exact mechanism for this is unclear, however, is most likely to occur due to reaction of free nitrates, TNT, PETN, inorganic or organic constituents of the Pentolite formulation. The interaction of these with XO or its reaction products through reactive oxygen species, or other intermediates may initiate a cascade whereby breakdown products are in turn reactive. This process may be synergistic or truly catalytic under appropriate conditions.
This example further demonstrates that both Xanthine and Hypoxanthine oxidation can lead to efficient degradation of Pentolite. Whilst hypoxanthine can be postulated to supply twice the degrading capacity, it is quite soluble and may dissolve faster than the target compounds, in this case PETN and TNT, thus limiting its utility in high water flow situations. Xanthine, which is significantly less soluble, would thus provide a rate of release more analogous to PETN and thus prove more effective in target degradation.
The relative quantities of Xanthine and Hypoxanthine will thus need to be adapted on the basis of a number of factors, including target solubility and environmental conditions. This example demonstrates one of these possibilities.
Experimental Bovine milk xanthine oxidase (Cat. No. X4875) was used in the examples below and was obtained from Sigma-Aldrich (Australia). Degradation assays were performed in 50 mM
potassium phosphate buffer (pH 7.2) with either 0.1 mM PETN or 100 ppm Pentolite as target substrate. Assays were performed in a volume of 3 ml and incubated for overnight at room temperature in the dark. Samples were then prepared for analysis by HPLC-UV by addition of 9 ml acetonitrile.
The following table demonstrates the degradation of PETN when 10mM xanthine is used as the oxidase substrate.
Degradation of PETN by XO (Xanthine substrate) Sample XO activity PETN PETN
(IU/L) (mg/L) degradation Xanthine Oxidase 500 2.8 66.3%
Control 0 8.3 0.0%
The following table compares the degradation of PETN as sole electron acceptor to the degradation of PETN as formulated Pentolite. Hypoxanthine (10 mM) was used as the oxidase substrate.
Degradation of Pentolite and PETN by 500 U/L XO (Hypoxanthine substrate) Sample presentation (mg/L) degradation (mg/L) degradation Xanthine Oxidase Pentolite <0.1 >98.6% <0.1 >99.3%
Control Pentolite 6.9 0.0% 14 0.0%
Xanthine Oxidase PETN 4.4 39.7% ND ND
Control PETN 7.3 0.0% ND ND
This significant enhancement of PETN degradation when presented to XO as Pentolite was reproducibly observed and is both significant and novel.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form of suggestion that that prior art forms part of the common general knowledge in Australia.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form of suggestion that that prior art forms part of the common general knowledge in Australia.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
Claims (14)
1. A method of deactivating an explosive composition provided in an explosive cartridge, which method comprises contacting the explosive composition with a deactivating agent in a form that renders the explosive composition insensitive to detonation after a predetermined period of time, wherein the deactivating agent is provided in the explosive cartridge and wherein the deactivating agent is an enzyme used in isolation from any living cell with which it might normally be associated or produced.
2. A method according to claim 1, wherein the enzyme is present in a laundry or dishwasher detergent.
3. A method according to claim 1, wherein the enzyme is provided with a co-factor.
4. A method according to claim 1, wherein the explosive composition is desensitised through the combined activity of the deactivating agent and another reagent useful in deactivating the explosive composition.
5. A method according to claim 4, wherein the another reagent is a reagent external to the explosive cartridge that will find its way or be introduced into the cartridge during use thereof and that can contribute to desensitisation of the explosive composition.
6 A method according to claim 1, wherein the deactivating agent is provided in or in contact with the explosive composition, and wherein to effect desensitisation of the explosive composition the deactivating agent must be contacted with water that enters or is delivered into the cartridge when used.
7. A method to claim 1, wherein the deactivating agent is provided separately from the explosive composition with the two coming into contact after a predetermined period of time.
8. A method according to claim 1, wherein the deactivating agent is provided separate to the explosive composition and must be mobilised in order for contact with the explosive composition to take place, and wherein the deactivating agent is provided in a suitable form that is rendered mobile by water that enters or is delivered into the explosive cartridge when used.
9. A method according to claim 8, wherein a water-permeable membrane separates the explosive composition and deactivating agent with the deactivating agent permeating this membrane when mobilised by contact with water.
10. A method according to claim 9, wherein the deactivating agent is provided in a water-degradable or water-soluble packet or wrapper.
11. A method according to claim 8, wherein the explosive cartridge includes one or more inlets and/or water-degradable pathways to allow environmental water to flow into the cartridge and directly into contact with the deactivating agent.
12. A method according to claim 8 or 11, wherein the explosive cartridge includes one or more inlets and/or water-degradable pathways to allow environmental water to flow into the cartridge and into contact with the deactivating agent through the explosive composition.
13. A method according to claim 12, wherein the explosive composition includes channels to allow water to migrate to the deactivating agent.
14. Use of an explosive cartridge according to claim 1 in a seismic survey application, wherein the explosive cartridge takes the form of a seismic charge.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2008900469 | 2008-02-01 | ||
AU2008900469A AU2008900469A0 (en) | 2008-02-01 | Improved methold of blasting | |
AU2008904879A AU2008904879A0 (en) | 2008-09-19 | Further improved method of blasting | |
AU2008904879 | 2008-09-19 | ||
PCT/AU2009/000103 WO2009094716A1 (en) | 2008-02-01 | 2009-01-30 | Deactivating an explosive composition using enzymes |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2714551A1 true CA2714551A1 (en) | 2009-08-06 |
CA2714551C CA2714551C (en) | 2016-10-11 |
Family
ID=40912173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2714551A Active CA2714551C (en) | 2008-02-01 | 2009-01-30 | Deactivating an explosive composition using enzymes |
Country Status (11)
Country | Link |
---|---|
US (1) | US8754284B2 (en) |
EP (1) | EP2242988B1 (en) |
AR (1) | AR070851A1 (en) |
AU (1) | AU2009208389B2 (en) |
BR (1) | BRPI0907049A2 (en) |
CA (1) | CA2714551C (en) |
CL (1) | CL2009000215A1 (en) |
MX (1) | MX2010008407A (en) |
PE (1) | PE20100007A1 (en) |
WO (1) | WO2009094716A1 (en) |
ZA (1) | ZA201006176B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2714548C (en) * | 2008-02-01 | 2017-03-14 | Orica Explosives Technology Pty Ltd. | Device for improved method of blasting |
NO2305624T3 (en) * | 2009-10-01 | 2018-02-24 | ||
AU2013214684C1 (en) * | 2012-02-02 | 2015-12-24 | Orica International Pte Ltd | Microbial deactivation of explosive compositions |
RU2567842C1 (en) * | 2014-10-27 | 2015-11-10 | Федеральное государственное бюджетное учреждение "Всероссийский научно-исследовательский институт по проблемам гражданской обороны и чрезвычайных ситуаций МЧС России" (федеральный центр науки и высоких технологий) | Method of complex processing of objects with application of combined indicator composition for processing of premises after acts of terrorism |
CA2965705C (en) * | 2014-10-27 | 2021-02-23 | Dyno Nobel Asia Pacific Pty Limited | Explosive composition for soft and wet ground and method of delivery |
US10351485B1 (en) * | 2016-10-24 | 2019-07-16 | Nevada System of Higher Education on Behalf of the Desert Research Institute | Microbial passivation of explosive ordnance |
US11402191B2 (en) | 2020-06-01 | 2022-08-02 | Expro Americas, Llc | Explosive charge deactivation system and method |
CN115355778B (en) * | 2022-07-26 | 2023-05-16 | 中铁十六局集团有限公司 | Large-section gas tunnel blasting coal uncovering construction method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994023857A1 (en) * | 1993-04-09 | 1994-10-27 | Technology Applications, Inc. | Method and composition for remediating environmental contaminants |
PL188502B1 (en) * | 1995-07-11 | 2005-02-28 | Secr Defence | Detection and biological degradation of explosives |
US6120627A (en) * | 1995-11-17 | 2000-09-19 | The Ensign-Bickford Company | Explosive with bioremediating capacity |
GB2332432A (en) * | 1997-12-19 | 1999-06-23 | Secr Defence | Biodegradation of Trinitrotoluene (TNT) |
US20060246555A1 (en) * | 2002-07-12 | 2006-11-02 | Jalal Hawari | Degradation of cyclic nitramines |
-
2008
- 2008-09-24 US US12/232,825 patent/US8754284B2/en active Active
-
2009
- 2009-01-30 AU AU2009208389A patent/AU2009208389B2/en not_active Ceased
- 2009-01-30 BR BRPI0907049-4A patent/BRPI0907049A2/en not_active IP Right Cessation
- 2009-01-30 CL CL2009000215A patent/CL2009000215A1/en unknown
- 2009-01-30 EP EP09706716.9A patent/EP2242988B1/en not_active Not-in-force
- 2009-01-30 WO PCT/AU2009/000103 patent/WO2009094716A1/en active Application Filing
- 2009-01-30 PE PE2009000132A patent/PE20100007A1/en not_active Application Discontinuation
- 2009-01-30 CA CA2714551A patent/CA2714551C/en active Active
- 2009-01-30 MX MX2010008407A patent/MX2010008407A/en active IP Right Grant
- 2009-02-02 AR ARP090100338A patent/AR070851A1/en not_active Application Discontinuation
-
2010
- 2010-08-30 ZA ZA2010/06176A patent/ZA201006176B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2009208389B2 (en) | 2013-11-14 |
EP2242988A4 (en) | 2013-09-04 |
CL2009000215A1 (en) | 2009-12-18 |
US8754284B2 (en) | 2014-06-17 |
MX2010008407A (en) | 2010-09-07 |
AR070851A1 (en) | 2010-05-12 |
AU2009208389A1 (en) | 2009-08-06 |
ZA201006176B (en) | 2011-05-25 |
CA2714551C (en) | 2016-10-11 |
US20120282680A1 (en) | 2012-11-08 |
WO2009094716A1 (en) | 2009-08-06 |
EP2242988A1 (en) | 2010-10-27 |
BRPI0907049A2 (en) | 2020-08-18 |
EP2242988B1 (en) | 2015-12-16 |
PE20100007A1 (en) | 2010-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009208389B2 (en) | Deactivating an explosive composition using enzymes | |
CA2714013C (en) | Deactivating an explosive composition using a chemical | |
US8850984B2 (en) | Device for improved method of blasting | |
Snellinx et al. | Microbial consortia that degrade 2, 4-DNT by interspecies metabolism: isolation and characterisation | |
Christodoulatos et al. | Anaerobic biodegradation of nitroglycerin | |
Ndibe et al. | A review on biodegradation and biotransformation of explosive chemicals | |
EP2242986B1 (en) | Deactivating an explosive composition using plants | |
Chakraborty et al. | Counterbalancing common explosive pollutants (TNT, RDX, and HMX) in the environment by microbial degradation | |
AU2013214684C1 (en) | Microbial deactivation of explosive compositions | |
Nehrenheim et al. | Toxicity assessment and biodegradation potential of water-soluble sludge containing 2, 4, 6-trinitrotoluene | |
Seth-Smith | Microbial Degradation of RDX. | |
Bhaumik et al. | Biodegradation of glycerol trinitrate by activated sludge: Cosubstrate requirements, inhibition, and kinetics | |
Chakraborty et al. | common explosive pollutants (TNT, RDX, and HMX) in the environment by microbial degradation | |
Georgie | Biodegradation of 2, 4, 6 trinitrotoulene (TNT), pentaerythritol tetranitrate (PETN) & pentolite by environmental microbes | |
Maleki | Treatment and biodegradation of high explosives: a literature review | |
Husserl | BIODEGRADATION OF NITROGLYCERIN AS A GROWTH SUBSTRATE: A BASIS FOR NATURAL ATTENUATION AND | |
Maleki et al. | Treatment and biodegradation of the high explosives HMX, RDX, and TNT: A literature review | |
Davel et al. | BIODEGRADATION OF ENERGETIC COMPOUNDS UNDER VARYING CO-SUBSTRATE LOADING CONDITIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20131115 |